Professor Richard Scolyer

Clinical Professor
Pathology, Central Clinical School

Telephone +61 2 9515 7458
Fax +61 2 9515 8405

Map

Biographical details

Richard A. Scolyer BMedSci, MBBS, MD, FRCPA, FRCPath

Consultant Pathologist and Co-Director of Research, Melanoma Institute Australia

Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney

Clinical Professor, Sydney Medical School, The University of Sydney

National Health and Medical Research Council Practitioner Fellow

Richard Scolyer studied medicine at the University of Tasmania (BMedSci, MBBS). After completing clinical training in Australia and overseas, he undertook pathology training at the Canberra Hospital and at the Royal Prince Alfred Hospital leading to Fellowship of the Royal College of Pathologists of Australasia. Richard is currently Consultant Pathologist and Co-Director of Research, Melanoma Institute Australia; Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; and Clinical Professor, The University of Sydney.

Richard has presented on more than 150 occasions at conferences throughout the world, and is a co-author of more than 340 articles and book chapters on melanocytic pathology and related research. In 2006, Richard was awarded the degree of Doctor of Medicine by The University of Sydney for his thesis of publications on melanocytic pathology. He received a NSW Premier's Award for Outstanding Cancer Research in 2009 and 2012. He is also an editorial board member of the American Journal of Surgical Pathology, a member of the International Editorial Advisory Board of Histopathology and Senior Associate Editor of Pathology. In 2013, Richard was appointed Vice Chair of the Melanoma Expert Panel of the American Joint Committee on Cancer (AJCC) for the 8th edition of their Cancer Staging System. He is currently President-Elect of the Australasian Division of the International Academy of Pathology. Together with other MIA colleagues, Richard is chief investigator on 5 year program grants from both the NHMRC and CINSW and he also has a personal Fellowship from the NHMRC.

Selected grants

2015

  • Hypoxic Chambers for Seahorse XF Extracellular Flux Analyzers; Richardson D, Scolyer R, Ng M, Murray M, Kril J; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2014

  • CLARIOstar Multifunctional Microplate Reader for Shared Used at the Open Access, Multi-User Molecular Biology Core Facility; Huang M, Scolyer R, Fraser S, Sahni S, Speranza T, Owens T, Barrs V, Ju Y, Kovacevic Z, Lu Z, Camp A, Slobedman B, Morris B, Oliver B, Dos Remedios C, Kalinowski D, Fu D, Lai D, Lovicu F, Allbutt H, Triccas J, Burgess J, Kril J, Dixon K, Rendina L, Byrne M, King N, Groundwater P, Williamson P, Ho J, Dong Q, Bao B, Assinder S, McLennan S, Richardson D, Ammit A, Sharland A, Hardikar A, Hong A, Hambly B, Lee C, Murphy C, Goldsbury C, Johnstone D, Lane D, Hibbs D, Joshua D, Huq F, Halliday G, Sutherland G, Zreiqat H, Lok H, Lyons G, Jansson P, Black J, Zhu L, Sunde M, Day M, Naylor M, Buckland M, Murray M, Shafie N, Lay P, Poronnik P, Codd R, Mason R, Ryan R, Christopherson R, de Graaf S; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2013

  • BioMark HD High-throughput Real Time & Digital PCR System for the Open Access, Multi-Disciplinary Sydney Cancer Research Core Facility; Richardson D, Scolyer R, Lee C, Halliday G, Murray M, Lay P, Christie M, Kench J, Damian D, Hersey P; Cancer Institute New South Wales/Equipment Grant.
  • Molecular determinants of progression and treatment response in melanoma; Scolyer R; National Health and Medical Research Council (NHMRC)/Career Awards: Practitioner Fellowships.
  • QX100 Droplet Digital PCR system for Shared Used at the Open Access, Multi-User Molecular Biology Core Facility; Richardson D, Kril J, Murphy C, Vandenberg R, Rendina L, Dos Remedios C, Ju Y, Kovacevic Z, Lyons G, Sutherland G, Lay P, Ammit A, Lai D, Morris B, Day M, Dong Q, Bao B, Huang M, Camp A, Boyer M, Whittington R, Byrne M, Hanrahan J, Fu D, Jansson P, Lane D, Bagley E, Hibbs D, Zhang D, Fraser S, Scolyer R, Black J, Halliday G, Christie M, Zreiqat H, Murray M, Slobedman B, Naylor M, Burgess J, Triccas J, Mason R, Chadban S, Combes V, Lovicu F, McLennan S, Kalinowski D, Sharland A, Johnstone D, Groundwater P, Dixon K, Zhou F, Lovejoy D, Lu Z, Zhu L, Goldsbury C, Witting P, Buckland M, Assinder S, Purdie (Williams) A, Codd R, Owens T, Hambly B; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Robotic High Throughput Western Analysis for the Open Access, Multi-User Sydney Cancer Research Core Facility; Richardson D, Scolyer R, Boyer M, Halliday G, Damian D, Christopherson R, Joshua D, Kench J, Hong A, Murray M, Lee C, Kalinowski D, Naylor M, Lay P, Lyons G, Kovacevic Z, Mason R, Dixon K, Chan-Ling T, Hawkins C, Sunde M, Lovejoy D, Owens T, Rendina L, Jansson P, Dos Remedios C, Charles (nee Slaviero) K, Lane D, Witting P, Dong Q, Ammit A, Groundwater P, Assinder S, Bao B, Byrne S, Zhou F, Buckland M, Grewal T, Huq F, Lai D, Codd R, Zhang D, Fu D, de Graaf S, Huang M, Payne R, Slobedman B, Barrs V, Ho J, Williamson P, Murphy C; DVC Research/Equipment Grant.
  • Cyber-racism and community resilience; Hayward N, Hersey P, Kefford R, Kefford R, Thompson J, Hersey P, Mann G, Scolyer R; National Health and Medical Research Council (NHMRC)/Program Grants.

2012

  • GeneAtlas Personal Microarray System; Richardson D, Scolyer R, Stocker R, Weninger W, Black J, Allen D, Murray M, Mason R, Twigg S, King N, Horvath L, Lovicu F, Lee C, Halliday G, Lovejoy D, Joshua D, Sharland A, Roufogalis B, Hambly B, Morris B, Bao B, Bishop A, Hibbs D, Lane D, Zhou F, Hanrahan J, Dixon K, Rendina L, Byrne M, Naylor M, Cole N, Jansson P, Dong Q, Codd R, Payne R, Assinder S, Chadban S, Fraser S, McLennan S, Suryo Rahmanto A, Lai D, Yu Y, Ju Y, Buckland M, Kovacevic Z, Saletta F, Zreiqat H, Kalinowski D, Groundwater P, Simes R, Zhang D, Boyer M, Murphy C; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2011

  • Melanoma Institute Australia Translational Research Program; Mann G, Thompson J, Kefford R, Menzies S, Scolyer R, Christopherson R, Rizos H, Spillane A, Zhang X, Hersey P; Cancer Institute New South Wales/Translational Program Grant.
  • PyroMark Q96 ID system; Richardson D, Stone J, Black J, King N, Mason R, Hunt N, Kril J, Murray M, Scolyer R, Halliday G, Vandenberg R, McMinn P, Chadban S, Byrne M, Ryan R, Dong Q, Lee C, Bishop A, Haass N, Fraser S, Hambly B, Sharland A, Kalinowski D, Assinder S, Yu Y, Bao B, Ju Y, Lovejoy D, Buckland M, Lane D, Dos Remedios C, Kovacevic Z, Sutherland G, Zhang D, Morris B, Suryo Rahmanto A, Murphy C; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2010

  • GenomeLab GeXP Genetic Analysis System for the Multi-Disciplinary Sydney Cancer Gene Expression Facility; Richardson D, Halliday G, Scolyer R, Clarke S, Lee C, Reichardt J, Clarke C, Murray M, Boyer M, Kefford R; Cancer Institute New South Wales/Equipment Grant.

2006

  • Molecular determinants of melanoma risk, progression and response to treatment; Kefford R, Thompson J, Hersey P, Mann G, Scolyer R; National Health and Medical Research Council (NHMRC)/Program Grants.
  • Sydney Melanoma Unit Translational Research Program; Mann G, Thompson J, Kefford R, Scolyer R, Menzies S, Hersey P, Christopherson R; Cancer Institute New South Wales/Translational Research Program Grant.

Selected publications

Download citations: PDF RTF Endnote

Edited Books

  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2005). Micromorphometric features of positive sentinel nodes predict involvement of non-sentinel nodes in patients. United States: Mosby.

Book Chapters

  • Schatton, T., Scolyer, R., Thompson, J., Mihm Jnr, M. (2014). Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. In Magdalena Thurim, Francesco M. Marincola (Eds.), Molecular Diagnostics for Melanoma: Methods and Protocols, (pp. 287-324). New York: Humana Press. [More Information]
  • Ashford, R., Scolyer, R., McCarthy, S., Bonar, S., Karim, R., Stalley, P. (2009). The role of intra-operative pathological evaluation in the management of musculo-skeletal tumours. In Tunn, Per-Ulf (Eds.), Treatment of Bone and Soft Tissue Sarcomas, (pp. 11-24). Germany: Springer.
  • Scolyer, R., Tan, K. (2007). Case 2: Unsuspected Merkel cell carcinoma. In A Zembowicz (Eds.), Critical Diagnoses in Dermatopathology, (pp. 9-19). Australia: Knowledge Books and Software.
  • McCarthy, S., Scolyer, R., Murali, R. (2007). Combined melanocytic lesion with a predominant component 105 of atypical deep penetrating nevus associated with nodal metastases. In A Zembowicz (Eds.), Cases in Dermatopathology: Common Problems in Diagnosis of Pigmented Lesions, (pp. 105-123). Australia: Knowledge Books and Software.
  • Murali, R., Scolyer, R. (2007). Pigmented dermatofibrosarcoma protuberans (Bednar tumor). In A Zembowicz (Eds.), Cases in Dermatopathology: Common Problems in Diagnosis of Pigmented Lesions, (pp. 199-201). Australia: Knowledge Books and Software.
  • Murali, R., McCarthy, S., Scolyer, R. (2006). Case 16: Atypical deep penetrating nevus forming a component of a combined nevus. In A Zembowicz (Eds.), Cases in Dermatopathology: Common Problems in Diagnosis of Pigmented Lesions, (pp. 105-124). Australia: Knowledge Books and Software.
  • McCarthy, S., Crotty, K., Scolyer, R. (2006). Desmoplastic melanoma and desmoplastic neurotropic melanoma. In LeBoit P; Burg G; Weedon D; Sarasin A (Eds.), Pathology and Genetics of Skin Tumours, (pp. 76-78). Lyon: IARC Press.
  • de Vries, E., Bray, F., Coebergh, J., Cerroni, L., RUITER, D., Elder, D., Thompson, J., Barnhill, R., van Muijen, G., Scolyer, R., et al (2006). Malignant melanoma: Introduction. In LeBoit P; Burg G; Weedon D; Sarasin A (Eds.), Pathology and Genetics of Skin Tumours, (pp. 52-65). Lyon: IARC Press.
  • Murali, R., Scolyer, R. (2006). Pigmented dermatofibrosarcoma protruberans (Bednar tumor). In A Zembowicz (Eds.), Cases in Dermatopathology: Common Problems in Diagnosis of Pigmented Lesions, (pp. 199-212). Australia: Knowledge Books and Software.
  • Thompson, J., Bishop, J., Scolyer, R. (2006). Primary melanoma of the lung. In Derek Raghavan, Martin L Brecher and David H Johnson etal (Eds.), Textbook of Uncommon Cancer, (pp. 293-297). United States: John Wiley & Sons.
  • Scolyer, R. (2005). Case 12: Nipple Adenoma. In A Zembowicz (Eds.), Cases in Dermatopathology: Adnexal Neoplasms, (pp. 83-98). Australia: Knowledge Books and Software.
  • Scolyer, R. (2005). Case 13: Digital Papillary Adenocarcinoma. In A Zembowicz (Eds.), Cases in Dermatopathology: Adnexal Neoplasms, (pp. 99-109). Australia: Knowledge Books and Software.
  • Harper, C., Scolyer, R. (2004). Alcoholism and dementia. In Margaret M. Esiri, Virginia Lee, John Q. Trojanowski (Eds.), The Neuropathology of Dementia. 2nd edition, (pp. 427-441). Cambridge University Press.

Journals

  • Jayawardana, K., Schramm, S., Haydu, L., Thompson, J., Scolyer, R., Mann, G., Muller, S., Yang, J. (2015). Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information. International Journal of Cancer, 136(4), 863-874. [More Information]
  • Dutton-Regester, K., Gartner, J., Emmanuel, R., Qutob, N., Davies, M., Gershenwald, J., Robinson, W., Robinson, S., Rosenberg, S., Scolyer, R., Mann, G., Thompson, J., et al (2014). A highly recurrent RPS27 5'UTR mutation in melanoma. Oncotarget, 5(10), 2912-2917.
  • Vilain, R., Wilmott, J., Scolyer, R. (2014). A light shines on melanoma metastagenesis. Pigment Cell & Melanoma Research, 25(7), 696-697. [More Information]
  • Shi, H., Hong, A., Kong, X., Koya, R., Song, C., Moriceau, G., Hugo, W., Yu, C., Ng, C., Chodon, T., Scolyer, R., Kefford, R., Long, G., et al (2014). A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition. Cancer Discovery, 4(1), 69-79. [More Information]
  • Wouters, J., Stas, M., Govaere, O., Barrette, K., Dudek, A., Vankelecom, H., Haydu, L., Thompson, J., Scolyer, R., van den Oord, J. (2014). A novel hypoxia-associated subset of FN1(high)MITF(low) melanoma cells: identification, characterization, and prognostic value. Modern Pathology, 27(8), 1088-1100. [More Information]
  • McCormack, C., Conyers, R., Scolyer, R., Kirkwood, J., Speakman, D., Wong, N., Kelly, J., Henderson, M. (2014). Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy. Melanoma Research, 24(5), 437-447. [More Information]
  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014). BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research, 20(7), 1965-1977. [More Information]
  • Kakavand, H., Crainic, O., Lum, T., O'Toole, S., Kefford, R., Thompson, J., Wilmott, J., Long, G., Scolyer, R. (2014). Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas. Pathology, 46(3), 193-198. [More Information]
  • Carlino, M., Haydu, L., Kakavand, H., Menzies, A., Hamilton, A., Yu, B., Ng, C., Cooper, W., Thompson, J., Kefford, R., O'Toole, S., Scolyer, R., Long, G. (2014). Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma. British Journal of Cancer, 111(2), 292-299. [More Information]
  • Sebaratnam, D., Martin, L., Venugopal, S., Mangos, G., Freiman, J., de Souza, P., Farnsworth, A., Cheung, K., Scolyer, R., Murrell, D. (2014). Diffuse melanosis cutis in the setting of BRAFV 600 E metastatic melanoma. International Journal Of Dermatology, 53(11), 1409-1411. [More Information]
  • Marzese, D., Scolyer, R., Roqué, M., Vargas-Roig, L., Huynh, J., Wilmott, J., Murali, R., Buckland, M., Barkhoudarian, G., Thompson, J., et al (2014). DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations. Neuro-Oncology, 16(11), 1499-1509. [More Information]
  • Wilmott, J., Haydu, L., Menzies, A., Lum, T., Hyman, J., Thompson, J., Hersey, P., Kefford, R., Scolyer, R., Long, G. (2014). Dynamics of chemokine, cytokine, and growth factor serum levels in BRAF-mutant melanoma patients during BRAF inhibitor treatment. The Journal of Immunology, 192(5), 2505-2513. [More Information]
  • Marzese, D., Scolyer, R., Huynh, J., Huang, S., Hirose, H., Chong, K., Kiyohara, E., Wang, J., Kawas, N., Donovan, N., Buckland, M., Thompson, J., et al (2014). Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Human Molecular Genetics, 23(1), 226-238. [More Information]
  • Lezcano, C., Lee, C., Larson, A., Menzies, A., Kefford, R., Thompson, J., Mihm, M., Ogino, S., Long, G., Scolyer, R., et al (2014). Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors. Modern Pathology, 27(9), 1193-1202. [More Information]
  • Griewank, K., Scolyer, R., Thompson, J., Flaherty, K., Schadendorf, D., Murali, R. (2014). Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects. Journal of the National Cancer Institute, 106(2), 1-17. [More Information]
  • Griewank, K., van de Nes, J., Schilling, B., Moll, I., Sucker, A., Kakavand, H., Haydu, L., Asher, M., Zimmer, L., Hillen, U., Thompson, J., Scolyer, R., et al (2014). Genetic and clinico-pathologic analysis of metastatic uveal melanoma. Modern Pathology, 27(2), 175-183. [More Information]
  • Gerami, P., Busam, K., Cochran, A., Cook, M., Duncan, L., Elder, D., Fullen, D., Guitart, J., LeBoit, P., Mihm, M., Scolyer, R., et al (2014). Histomorphologic Assessment and Interobserver Diagnostic Reproducibility of Atypical Spitzoid Melanocytic Neoplasms With Long-term Follow-up. The American Journal of Surgical Pathology, 38(7), 934-940. [More Information]
  • Zimmer, L., Haydu, L., Menzies, A., Scolyer, R., Kefford, R., Thompson, J., Schadendorf, D., Long, G. (2014). Incidence of New Primary Melanomas After Diagnosis of Stage III and IV Melanoma. Journal of Clinical Oncology, 32(8), 816-823. [More Information]
  • Long, G., Fung, C., Menzies, A., Pupo, G., Carlino, M., Hyman, J., Shahheydari, H., Tembe, V., Thompson, J., Saw, R., Howle, J., Scolyer, R., Kefford, R., Rizos, H., et al (2014). Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma. Nature Communications, 5, 1-9. [More Information]
  • Gopal, V., Rizos, H., Chen, G., Deng, W., Frederick, D., Cooper, Z., Scolyer, R., Pupo, G., Komurov, K., Sehgal, V., Long, G., et al (2014). Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma. Cancer Research, 74(23), 7037-7047. [More Information]
  • Menzies, A., Wilmott, J., Long, G., Scolyer, R. (2014). Intra-patient heterogeneity of BRAF mutation status: fact or fiction? British Journal of Cancer, 111(8), 1678-1679. [More Information]
  • Menzies, A., Lum, T., Wilmott, J., Hyman, J., Kefford, R., Thompson, J., O'Toole, S., Long, G., Scolyer, R. (2014). Intrapatient Homogeneity of BRAFV600E Expression in Melanoma. The American Journal of Surgical Pathology, 38(3), 377-382. [More Information]
  • Larson, A., Dresser, K., Zhan, Q., Lezcano, C., Woda, B., Yosufi, B., Thompson, J., Scolyer, R., Mihm, M., Shi, Y., et al (2014). Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Modern Pathology, 27(7), 936-944. [More Information]
  • van der Ploeg, A., Haydu, L., Spillane, A., Scolyer, R., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2014). Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease. Annals of Surgical Oncology, 21(9), 3108-3116. [More Information]
  • Becker, T., Boyd, S., Mijatov, B., Gowrishankar, K., Snoyman, S., Pupo, G., Scolyer, R., Mann, G., Kefford, R., Zhang, X., Rizos, H. (2014). Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor. Oncogene, 33(9), 1158-1166. [More Information]
  • Liu, Y., Lai, F., Wilmott, J., Yan, X., Liu, X., Luan, Q., Guo, S., Jiang, C., Tseng, H., Scolyer, R., et al (2014). Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells. Oncotarget, 5(22), 11237-11251.
  • Dong, L., Jin, L., Tseng, H., Wang, C., Wilmott, J., Yosufi, B., Yan, X., Jiang, C., Jiang, C., Scolyer, R., et al (2014). Oncogenic suppression of PHLPP1 in human melanoma. Oncogene, 33(39), 4756-4766. [More Information]
  • van der Ploeg, A., Haydu, L., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R., Scolyer, R., Thompson, J. (2014). Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution. Annals of Surgery, 260(1), 149-157. [More Information]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2014). Pathology Review Significantly Affects Diagnosis and Treatment of Melanoma Patients: An Analysis of 5011 Patients Treated at a Melanoma Treatment Center. Annals of Surgical Oncology, 21(7), 2245-2251. [More Information]
  • Carlino, M., Fung, C., Shahheydari, H., Todd, J., Boyd, S., Irvine, M., Nagrial, A., Scolyer, R., Kefford, R., Long, G., Rizos, H. (2014). Pre-existing MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients. Clinical Cancer Research, 21(1), 98-105. [More Information]
  • Song, E., Scolyer, R., Damian, D., Thompson, J. (2014). Primary oesophageal melanoma - a case report. World Journal of Surgical Oncology, 12(1), 77-77. [More Information]
  • Mactier, S., Kaufman (nee Alexander), K., Wang, P., Crossett, B., Pupo, G., Kohnke, P., Thompson, J., Scolyer, R., Yang, J., Mann, G., Christopherson, R. (2014). Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients. Pigment Cell & Melanoma Research, 27(6), 1106-1116. [More Information]
  • Fogarty, G., Hong, A., Scolyer, R., Lin, E., Haydu, L., Guitera, P., Thompson, J. (2014). Radiotherapy for lentigo maligna - a literature review and recommendations for treatment. British Journal of Dermatology, 170(1), 52-58. [More Information]
  • Zimmer, L., Haydu, L., Menzies, A., Scolyer, R., Kefford, R., Thompson, J., Schadendorf, D., Long, G. (2014). Reply to M. Perier-Muzet et al. Journal of Clinical Oncology, 32(28), 3203-3204. [More Information]
  • Parmenter, T., Kleinschmidt, M., Kinross, K., Bond, S., Li, J., Kaadige, M., Rao, A., Sheppard, K., Hugo, W., Pupo, G., Long, G., Scolyer, R., Rizos, H., et al (2014). Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discovery, 4(4), 423-433. [More Information]
  • Kaufman (nee Alexander), K., Mactier, S., Armstrong, N., Mallawaaratchy, D., Byrne, S., Haydu, L., Jakrot, V., Thompson, J., Mann, G., Scolyer, R., Christopherson, R. (2014). Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients. Clinical and Experimental Metastasis, 31, 407-421. [More Information]
  • Guitera, P., Haydu, L., Menzies, S., Scolyer, R., Hong, A., Fogarty, G., Gallardo, F., Segura, S. (2014). Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors. British Journal of Dermatology, 170(6), 1305-1312. [More Information]
  • Chien, A., Haydu, L., Biechele, T., Kulikauskas, R., Rizos, H., Kefford, R., Scolyer, R., Moon, R., Long, G. (2014). Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/Beta-Catenin Signaling. PloS One, 9(4), 1-11.
  • Lamboo, L., Haydu, L., Scolyer, R., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Bonenkamp, J., Thompson, J. (2014). The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in thickness): A retrospective study of 1587 patients treated at a single center. Annals of Surgery, 260(6), 1095-1102. [More Information]
  • van der Ploeg, A., Akkooi, A., Haydu, L., Scolyer, R., Murali, R., Verhoef, C., Thompson, J., Eggermont, A. (2014). The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. European Journal of Cancer, 50(1), 111-120. [More Information]
  • Sutton, S., Koach, J., Tan, O., Liu, B., Carter, D., Wilmott, J., Yosufi, B., Haydu, L., Mann, G., Thompson, J., Long, G., Scolyer, R., et al (2014). TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells. Oncotarget, 5(20), 10127-10139.
  • Hu, W., Jin, L., Jiang, C., Long, G., Scolyer, R., Wu, Q., Zhang, X., Mei, Y., Wu, M. (2013). AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma. Cell Death and Disease, 4(11), 1-11. [More Information]
  • Wevers, K., Murali, R., Bastiaannet, E., Scolyer, R., Suurmeijer, A., Thompson, J., Hoekstra, H. (2013). Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients. European Journal of Surgical Oncology, 39(2), 179-184. [More Information]
  • Bogun, Y., Scolyer, R., Guitera, P. (2013). Asymptomatic linear pigmentation of the skin. International Journal Of Dermatology, 52(8), 935-937. [More Information]
  • Murali, R., Wilmott, J., Jakrot, V., Al-Ahmadie, H., Wiesner, T., McCarthy, S., Thompson, J., Scolyer, R. (2013). BAP1 expression in cutaneous melanoma: a pilot study. Pathology, 45(6), 606-609. [More Information]
  • Scolyer, R., Thompson, J. (2013). Biospecimen banking: The pathway to personalized medicine for patients with cancer. Journal of Surgical Oncology, 107(7), 681-682. [More Information]
  • Mann, G., Pupo, G., Campain, A., Carter, C., Schramm, S., Pianova, S., Gerega, S., Desilva, C., Lai, K., Wilmott, J., Hersey, P., Kefford, R., Thompson, J., Yang, J., Scolyer, R., et al (2013). BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma. Journal of Investigative Dermatology, 133(2), 509-517. [More Information]
  • Wilmott, J., Menzies, A., Haydu, L., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Diemling, A., Scolyer, R., Long, G. (2013). BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma. British Journal of Cancer, 108(4), 924-931. [More Information]
  • Mar, V., Wong, S., Li, J., Scolyer, R., McLean, C., Papenfuss, A., Tothill, R., Kakavand, H., Mann, G., Thompson, J., et al (2013). BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage. Clinical Cancer Research, 19(17), 4589-4598. [More Information]
  • Murali, R., Scolyer, R., Thompson, J. (2013). Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes. European Journal of Surgical Oncology, 39(10), 1164-1165. [More Information]
  • Shiau, C., Thompson, J., Scolyer, R. (2013). Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna. Expert Review of Dermatology, 8(2), 195-214. [More Information]
  • Scolyer, R., Judge, M., Evans, A., Frishberg, D., Prieto, V., Thompson, J., Trotter, M., Walsh, M., Walsh, N., Ellis, D. (2013). Data set for pathology reporting of cutaneous invasive melanoma: Recommendations from the international collaboration on cancer reporting (ICCR). The American Journal of Surgical Pathology, 37(12), 1797-1814. [More Information]
  • Menzies, S., Moloney, F., Byth Wilson, K., Avramidis, M., Argenziano, G., Zalaudek, I., Braun, R., Malvehy, J., Puig, S., Rabinovitz, H., Scolyer, R., Guitera, P., Coates, E., et al (2013). Dermoscopic evaluation of nodular melanoma. JAMA Dermatology, 149(6), 699-709. [More Information]
  • Scolyer, R., Karim, R., Thompson, J., Stretch, J., McCarthy, S., Murali, R. (2013). Digital papillary adenocarcinoma: a tumour that should be considered in the differential diagnosis of neoplasms involving the digits. Pathology, 45(1), 55-61. [More Information]
  • Schramm, S., Li, S., Jayaswal, V., Fung, D., Campain, A., Pang, C., Scolyer, R., Yang, J., Mann, G., Wilkins, M. (2013). Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden. Pigment Cell & Melanoma Research, 26(5), 708-722. [More Information]
  • Long, G., Wilmott, J., Haydu, L., Tembe, V., Sharma, R., Rizos, H., Thompson, J., Howle, J., Scolyer, R., Kefford, R. (2013). Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment and on progression. Pigment Cell & Melanoma Research, 26(4), 499-508. [More Information]
  • Kakavand, H., Scolyer, R., Thompson, J., Mann, G. (2013). Identification of new prognostic biomarkers for Stage III metastatic melanoma patients. OncoImmunology, 2(9), e25564-1-e25564-3. [More Information]
  • Long, G., Wilmott, J., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Deimling, A., Scolyer, R. (2013). Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma. The American Journal of Surgical Pathology, 37(1), 61-65. [More Information]
  • Guitera, P., Moloney, F., Menzies, S., Stretch, J., Quinn, M., Hong, A., Fogarty, G., Scolyer, R. (2013). Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy. JAMA Dermatology, 149(6), 692-698. [More Information]
  • Ryu, S., Robyn, S., Scolyer, R., Crawford, M., Thompson, J., Sandroussi, C. (2013). Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries. Journal of Surgical Oncology, 108(2), 129-135. [More Information]
  • Pasquali, S., van der Ploeg, A., Mocellin, S., Stretch, J., Thompson, J., Scolyer, R. (2013). Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell & Melanoma Research, 26(3), 326-337. [More Information]
  • Harish, V., Bond, J., Scolyer, R., Haydu, L., Saw, R., Quinn, M., Benger, R., Uren, R., Stretch, J., Shannon, K., Thompson, J. (2013). Margins of excision and prognostic factors for cutaneous eyelid melanomas. Journal of Plastic, Reconstructive and Aesthetic Surgery, 66(8), 1066-1073. [More Information]
  • Dutton-Regester, K., Kakavand, H., Aoude, L., Stark, M., Gartside, M., Johansson, P., O'Connor, L., Lanagan, C., Tembe, V., Pupo, G., Haydu, L., Mann, G., Thompson, J., Scolyer, R., et al (2013). Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma. Pigment Cell & Melanoma Research, 26(6), 852-860. [More Information]
  • Scolyer, R., Thompson, J. (2013). Mitotic rate in melanoma should be recorded as the number of mitoses per mm(2) (not per high power field): surgeons tell your pathologists!. The American Journal Of Surgery, 206(1), 142-143. [More Information]
  • Murali, R., Scolyer, R., Armstrong, B. (2013). Multiple primary cutaneous melanomas: recent studies highlight features associated with more indolent behaviour. Pathology, 45(1), 1-3. [More Information]
  • Boyd, S., Mijatov, B., Pupo, G., Tran, S., Gowrishankar, K., Shaw, H., Goding, C., Scolyer, R., Mann, G., Kefford, R., Rizos, H., Becker, T. (2013). Oncogenic B-RAF(V600E) Signaling Induces the T-Box3 Transcriptional Repressor to Repress E-Cadherin and Enhance Melanoma Cell Invasion. Journal of Investigative Dermatology, 133(5), 1269-1277. [More Information]
  • Gerami, P., Cooper, C., Bajaj, S., Wagner, A., Fullen, D., Busam, K., Scolyer, R., Xu, X., Elder, D., Abraham, R., et al (2013). Outcomes of atypical spitz tumors with chromosomal copy number aberrations and conventional melanomas in children. American Journal of Surgical Pathology, 37(9), 1387-1394. [More Information]
  • Fung, C., Pupo, G., Scolyer, R., Kefford, R., Rizos, H. (2013). p16INK4a deficiency promotes DNA hyper-replication and genetic instability in melanocytes. Pigment Cell & Melanoma Research, 26(2), 236-246. [More Information]
  • Sarchio, S., Scolyer, R., Beaugie, C., McDonald, D., Marsh-Wakefield, F., Halliday, G., Byrne, S. (2013). Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer. Journal of Investigative Dermatology, 134(4), 1091-1100. [More Information]
  • Ye, Y., Jin, L., Wilmott, J., Hu, W., Yosufi, B., Thorne, R., Liu, T., Rizos, H., Yan, X., Dong, L., Hersey, P., Scolyer, R., et al (2013). PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma. Nature Communications, 4, 1-15. [More Information]
  • Delahunt, B., Scolyer, R., Srigley, J. (2013). Premalignancy: The lull before the storm. Pathology, 45(3), 207-208. [More Information]
  • Karim, R., O'Toole, S., Scolyer, R., Cooper, C., Chan, B., Selinger, C., Yu, B., Carmalt, H., Mak, C., Tse, G., Lee, C., et al (2013). Recent insights into the molecular pathogenesis of mammary phyllodes tumours. Journal of Clinical Pathology, 66(6), 496-505. [More Information]
  • Guitera, P., Scolyer, R., Gill, M., Akita, H., Arima, M., Yokoyama, Y., Matsunaga, K., Longo, C., Bassoli, S., Bencini, P., et al (2013). Reflectance confocal microscopy for diagnosis of mammary and extramammary Paget's disease. European Academy of Dermatology and Venereology. Journal, 27(1), e24-e29. [More Information]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2013). Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases. Annals of Surgical Oncology, 20(12), 3969-3975. [More Information]
  • Gerami, P., Scolyer, R., Xu, X., Elder, D., Abraham, R., Fullen, D., Prieto, V., LeBoit, P., Barnhill, R., Cooper, C., et al (2013). Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. American Journal of Surgical Pathology, 37(5), 676-684. [More Information]
  • Cho, E., Moloney, F., Cai, H., Au-Yeung, A., China, C., Scolyer, R., Yosu�?, B., Raftery, M., Deng, J., Morton, S., Damian, D., Barnetson, R., Halliday, G., et al (2013). Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). The Lancet, 381(9880), 1835-1843. [More Information]
  • Pasquali, S., Haydu, L., Scolyer, R., Winstanley, J., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2013). The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas. Annals of Surgery, 258(1), 152-157. [More Information]
  • Hruby, G., Scolyer, R., Thompson, J. (2013). The important role of radiation treatment in the management of Merkel cell carcinoma. British Journal of Dermatology, 169(5), 975-982. [More Information]
  • Murali, R., Wiesner, T., Scolyer, R. (2013). Tumours associated with BAP1 mutations. Pathology, 45(2), 116-126. [More Information]
  • Dutton-Regester, K., Irwin, D., Hunt, P., Aoude, L., Tembe, V., Pupo, G., Lanagan, C., Carter, C., O'Connor, L., O'Rourke, M., Scolyer, R., Mann, G., et al (2012). A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma. Molecular Cancer Therapeutics, 11(4), 888-897. [More Information]
  • Huynh, K., Takei, Y., Scolyer, R., Murali, R., Chong, K., Takeshima, L., Sim, M., Morton, D., Turner, R., Thompson, J., et al (2012). Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma. British Journal of Dermatology, 166(6), 1319-1326. [More Information]
  • Tran, S., Haferkamp, S., Scurr, L., Gowrishankar, K., Becker, T., Desilva, C., Thompson, J., Scolyer, R., Kefford, R., Rizos, H. (2012). Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi. Journal of Investigative Dermatology, 132(9), 2226-2234. [More Information]
  • Burmeister, B., Henderson, M., Ainslie, J., Fisher, R., Dilulio, J., Smithers, B., Hong, A., Shannon, K., Scolyer, R., Carruthers, S., Thompson, J., et al (2012). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. The Lancet Oncology, 13(6), 589-597. [More Information]
  • Wilmott, J., Haydu, L., Bagot, M., Zhang, Y., Jakrot, V., McCarthy, S., Lugassy, C., Thompson, J., Scolyer, R., Jakrot, V., et al (2012). Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma. Histopathology, 61(5), 889-898. [More Information]
  • Murali, R., Scolyer, R., Thompson, J. (2012). Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death? Annals of Surgical Oncology, 19(11), 3310-3312. [More Information]
  • Murali, R., Haydu, L., Long, G., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Kefford, R., Thompson, J., Scolyer, R. (2012). Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma. Annals of Surgical Oncology, 19(6), 1782-1789. [More Information]
  • Murali, R., Goumas, C., Kricker, A., From, L., Busam, K., Begg, C., Dwyer, T., Gruber, S., Kanetsky, P., Orlow, I., Scolyer, R., Armstrong, B., et al (2012). Clinicopathologic Features of Incident and Subsequent Tumors in Patients with Multiple Primary Cutaneous Melanomas. Annals of Surgical Oncology, 19(3), 1024-1033. [More Information]
  • Wilmott, J., Scolyer, R., Long, G., Hersey, P. (2012). Combined targeted therapy and immunotherapy in the treatment of advanced melanoma. OncoImmunology, 1(6), 997-999. [More Information]
  • Anforth, R., Blumetti, T., Kefford, R., Sharma, R., Scolyer, R., Kossard, S., Long, G., Fernandez Penas, P. (2012). Cutaneous Manifestations of Dabrafenib (GSK2118436): A Selective Inhibitor of Mutant BRAF in patients with Metastatic Melanoma. British Journal of Dermatology, 167(5), 1153-1160. [More Information]
  • Koh, S., Wei, J., Li, X., Huang, R., Doan, N., Scolyer, R., Cochran, A., Binder, S. (2012). Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases. Modern Pathology, 25(6), 828-837. [More Information]
  • Menzies, A., Haydu, L., Visintin, L., Carlino, M., Howle, J., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2012). Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma. Clinical Cancer Research, 18(12), 3242-3249. [More Information]
  • Tsang, J., Mendoza, P., Putti, T., Karim, R., Scolyer, R., Lee, C., Pang, A., Tse, G. (2012). E-cadherin expression in the epithelial components of mammary phyllodes tumors. Human Pathology, 43(12), 2117-2123. [More Information]
  • Salim, A., Karim, R., McCarthy, S., Scolyer, R. (2012). Endocrine mucin producing sweat gland carcinoma: a clinicopathological analysis of three cases. Pathology, 44(6), 568-571. [More Information]
  • Huang, X., Scolyer, R., Abubakar, A., Halliday, G. (2012). Human 8-oxoguanine-DNA glycosylase-1 is downregulated in human basal cell carcinoma. Molecular Genetics and Metabolism, 106(1), 127-130. [More Information]
  • Dutton-Regester, K., Aoude, L., Nancarrow, D., Stark, M., O'Connor, L., Lanagan, C., Pupo, G., Tembe, V., Carter, C., O'Rourke, M., Scolyer, R., Mann, G., et al (2012). Identification of TFG (TRK-Fused Gene) as a Putative Metastatic Melanoma Tumor Suppressor Gene. Genes Chromosomes and Cancer, 51(5), 452-461. [More Information]
  • Guitera, P., Menzies, S., Longo, C., Cesinaro, A., Scolyer, R., Pellacani, G. (2012). In Vivo Confocal Microscopy for Diagnosis of Melanoma and Basal Cell Carcinoma Using a Two-Step Method: Analysis of 710 Consecutive Clinically Equivocal Cases. Journal of Investigative Dermatology, 132(10), 2386-2394. [More Information]
  • Lim, C., Whalley, D., Haydu, L., Murali, R., Tippett, J., Thompson, J., Hruby, G., Scolyer, R. (2012). Increasing Tumor Thickness is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma. Annals of Surgical Oncology, 19(11), 3325-3334. [More Information]
  • Wilmott, J., Tembe, V., Howle, J., Sharma, R., Thompson, J., Rizos, H., Lo, R., Kefford, R., Scolyer, R., Long, G. (2012). Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine. Molecular Cancer Therapeutics, 11(12), 2704-2708. [More Information]
  • Tsang, J., Mendoza, P., Lam, C., Yui, A., Putti, T., Karim, R., Scolyer, R., Lee, C., Tan, P., Tse, G. (2012). Involvement of a- and B-catenins and E-cadherin in the development of mammary phyllodes tumours. Histopathology, 61(4), 667-674. [More Information]
  • Lian, C., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., Scolyer, R., Thompson, J., Kakavand, H., et al (2012). Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma. Cell, 150(6), 1135-1146. [More Information]
  • Shayan, R., Karnezis, T., Murali, R., Wilmott, J., Ashton, M., Taylor, G., Thompson, J., Hersey, P., Achen, M., Scolyer, R., et al (2012). Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis. Histopathology, 61(4), 702-710. [More Information]
  • Shi, H., Moriceau, G., Kong, X., Lee, M., Lee, H., Koya, R., Ng, C., Chodon, T., Scolyer, R., Dahlman, K., Kefford, R., Long, G., et al (2012). Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance. Nature Communications, 3(20122), 1-8. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2012). Melanoma: A management guide for GPs. Australian Family Physician, 41(7), 470-473. [More Information]
  • Murali, R., Brown, P., Kefford, R., Scolyer, R., Thompson, J., Atkins, M., Long, G. (2012). Number of Primary Melanomas Is an Independent Predictor of Survival in Patients With Metastatic Melanoma. Cancer, 118(18), 4519-4529. [More Information]
  • Lim, C., Thompson, J., McKenzie, P., McCarthy, S., Scolyer, R. (2012). Peritoneal melanosis associated with metastatic melanoma involving the omentum. Pathology, 44(3), 255-257. [More Information]
  • in 't Hout, F., Haydu, L., Murali, R., Bonenkamp, J., Thompson, J., Scolyer, R. (2012). Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma. Annals of Surgery, 255(6), 1165-1170. [More Information]
  • Schramm, S., Campain, A., Scolyer, R., Yang, J., Mann, G. (2012). Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis. Journal of Investigative Dermatology, 132(2), 274-283. [More Information]
  • Wilmott, J., Long, G., Howle, J., Haydu, L., Sharma, R., Thompson, J., Kefford, R., Hersey, P., Scolyer, R. (2012). Selective BRAF inhibitors induce marked T - cell infiltration into human metastatic melanoma. Clinical Cancer Research, 18(5), 1386-1394. [More Information]
  • Scurr, L., McKenzie, H., Becker, T., Irvine, M., Lai, K., Mann, G., Scolyer, R., Kefford, R., Rizos, H. (2012). Selective Loss of Wild-Type p16(INK4a) Expression in Human Nevi. Journal of Investigative Dermatology, 131(11), 2329-2332. [More Information]
  • Murali, R., Haydu, L., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma. Annals of Surgery, 255(1), 128-133. [More Information]
  • Murali, R., Desilva, C., McCarthy, S., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Nodes Containing Very Small (<0.1 mm) Deposits of Metastatic Melanoma Cannot Be Safely Regarded as Tumor-Negative. Annals of Surgical Oncology, 19(4), 1089-1099. [More Information]
  • Girouard, S., Laga, A., Mihm, M., Scolyer, R., Thompson, J., Zhan, Q., Widlund, H., Lee, C., Murphy, G. (2012). SOX2 contributes to melanoma cell invasion. Laboratory Investigation, 92(3), 362-370. [More Information]
  • Chua, T., Scolyer, R., Kennedy, C., Yan, T., McCaughan, B., Thompson, J. (2012). Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients. Annals of Surgical Oncology, 19(6), 1774-1781. [More Information]
  • Halliday, G., Zhou, Y., Sou, P., Huang, X., Rana, S., Bugeja, M., Painter, N., Scolyer, R., Muchardt, C., Di Girolamo, N., Lyons, G. (2012). The absence of Brm exacerbates photocarcinogenesis. Experimental Dermatology, 21(8), 599-604. [More Information]
  • Cheung, B., Koach, J., Tan, O., Kim, P., Bell, J., D'andreti, C., Sutton, S., Malyukova, A., Sekyere, E., Norris, M., Wilmott, J., Cooper, C., Halliday, G., Scolyer, R., et al (2012). The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro. Journal of Pathology, 226(3), 451-462. [More Information]
  • Azimi, F., Scolyer, R., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S., Saw, R., Thompson, J. (2012). Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma. Journal of Clinical Oncology, 30(21), 2678-2683. [More Information]
  • Bauer, J., Buttner, P., Murali, R., Okamoto, I., Kolaitis, N., Landi, M., Scolyer, R., Bastian, B. (2011). BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell & Melanoma Research, 24(2), 345-351. [More Information]
  • Bock, V., Lyons, G., Huang, X., Jones, A., McDonald, L., Scolyer, R., Moloney, F., Barnetson, R., Halliday, G. (2011). BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. British Journal of Dermatology, 164(6), 1221-1227. [More Information]
  • Svobodova, S., Browning, J., MacGregor, D., Pollara, G., Scolyer, R., Murali, R., Thompson, J., Deb, S., Azad, A., Davis, I., et al (2011). Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. European Journal of Cancer, 47(3), 460-469. [More Information]
  • Murali, R., Zannino, D., Synnott, M., McCarthy, S., Thompson, J., Scolyer, R. (2011). Clinical and Pathological Features of Metastases of Primary Cutaneous Desmoplastic Melanoma. Histopathology, 58(6), 886-895. [More Information]
  • Scolyer, R., Long, G., Thompson, J. (2011). Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Molecular Oncology, 5(2), 124-136. [More Information]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2011). Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients. Annals of Surgery, 253(6), 1155-1164. [More Information]
  • Hollingsworth, J., Cooper, W., Nicoll, K., Wills, E., Thiruvilangam, V., Lee, C., Scolyer, R. (2011). Follicular dendritic cell sarcoma of the lung: a report of two cases highlighting its pathological features and diagnostic pitfalls. Pathology, 43(1), 67-70. [More Information]
  • Hersey, P., Smalley, K., Weeraratna, A., Bosenberg, M., Zhang, X., Haass, N., Paton, E., Mann, G., Scolyer, R. (2011). Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010. Pigment Cell & Melanoma Research, 24(1), e1-e15. [More Information]
  • Scolyer, R., Prieto, V. (2011). Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients. Surgical Oncology Clinics of North America, 20(1), 19-37. [More Information]
  • Schrama, D., Peitsch, W., Zapatka, M., Kneitz, H., Houben, R., Eib, S., Haferkamp, S., Moore, P., Shuda, M., Thompson, J., Scolyer, R., et al (2011). Merkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell Carcinoma. Journal of Investigative Dermatology, 131(8), 1631-1638. [More Information]
  • Jin, L., Hu, W., Jiang, C., Wang, J., Han, C., Chu, P., Zhang, L., Thorne, R., Wilmott, J., Scolyer, R., Hersey, P., et al (2011). MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proceedings of the National Academy of Sciences of the United States of America, 108(38), 15840-15845. [More Information]
  • Zembowicz, A., Scolyer, R. (2011). Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms? Archives of Pathology & Laboratory Medicine, 135(34), 300-306. [More Information]
  • Long, G., Menzies, A., Nagrial, A., Haydu, L., Hamilton, A., Mann, G., Hughes, T., Thompson, J., Scolyer, R., Kefford, R. (2011). Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma. Journal of Clinical Oncology, 29(10), 1239-1246. [More Information]
  • Nielsen, K., Chakera, A., Hesse, B., Scolyer, R., Stretch, J., Thompson, J., Nielsen, M., Uren, R., Oturai, P. (2011). The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. European Journal of Nuclear Medicine and Molecular Imaging, 38(11), 1999-2004. [More Information]
  • Wilmott, J., Zhang, X., Hersey, P., Scolyer, R. (2011). The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology, 43(6), 657-671. [More Information]
  • Verwer, N., Scolyer, R., Uren, R., Winstanley, J., Brown, P., de Wilt, J., Thompson, J. (2011). Treatment and Prognostic Significance of Positive Interval Sentinel Nodes in Patients with Primary Cutaneous Melanoma. Annals of Surgical Oncology, 18(12), 3292-3299. [More Information]
  • Kaufman (nee Alexander), K., Belov, L., Huang, P., Mactier, S., Scolyer, R., Mann, G., Christopherson, R. (2010). An extended antibody microarray for surface profiling metastatic melanoma. Journal of Immunological Methods, 358(40210 (1-2)), 23-34. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2010). Can Histologic Parameters of Melanoma Metastases in Sentinel Lymph Nodes Reliably Select Patients Who Can Be Safely Spared Completion Lymph Node Dissection? Annals of Surgery, 251(6), 1188-9; author reply 1189-90. [More Information]
  • Guitera, P., Bourgeat, P., Stretch, J., Scolyer, R., Ourselin, S., Lean, C., Thompson, J., Bourne, R. (2010). Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies. Melanoma Research, 20(4), 311-317. [More Information]
  • Murali, R., Thompson, J., Uren, R., Scolyer, R. (2010). Fine-needle biopsy of metastatic melanoma: clinical use and new applications. Lancet Oncology, 11(4), 391-400. [More Information]
  • Broekaert, S., Roy, R., Okamoto, I., van den Oord, J., Bauer, J., Garbe, C., Barnhill, R., Busam, K., Cochran, A., Cook, M., McCarthy, S., Scolyer, R., et al (2010). Genetic and morphologic features for melanoma classification. Pigment Cell & Melanoma Research, 23(6), 763-770. [More Information]
  • Goto, Y., Arigami, T., Murali, R., Scolyer, R., Tanemura, A., Takata, M., Turner, R., Nguyen, L., Nguyen, T., Morton, D., et al (2010). High Molecular Weight-Melanoma-Associated Antigen as a Biomarker of Desmoplastic Melanoma. Pigment Cell & Melanoma Research, 23(1), 137-40. [More Information]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2010). Histologically Ambiguous ("Borderline") Primary Cutaneous Melanocytic Tumors - Approaches to Patient Management Including the Roles of Molecular Testing and Sentinel Lymph Node Biopsy. Archives of Pathology and Laboratory Medicine, 134(12), 1770-1777. [More Information]
  • Scurr, L., Pupo, G., Becker, T., Lai, K., Schrama, D., Haferkamp, S., Irvine, M., Scolyer, R., Mann, G., Becker, J., Kefford, R., Rizos, H. (2010). IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence. Cell, 141(4), 717-727. [More Information]
  • Zhuang, L., Scolyer, R., Murali, R., McCarthy, S., Zhang, X., Thompson, J., Hersey, P. (2010). Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Modern Pathology, 23(1), 45-53. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2010). Location of Melanoma Metastases in Sentinel Lymph Nodes: What are the Implications for Histologic Processing of Sentinel Lymph Nodes in Routine Practice? The American Journal of Surgical Pathology, 34(1), 127-129. [More Information]
  • Verwer, N., Murali, R., Winstanley, J., Cooper, W., Stretch, J., Thompson, J., Scolyer, R. (2010). Lymphoma occurring in patients with cutaneous melanoma. Journal of Clinical Pathology, 63(9), 777-781. [More Information]
  • Field, A., McKenzie, P., McLeod, D., Stretch, J., Thompson, J., Scolyer, R. (2010). Melanotic schwannoma mimicking metastatic pigmented melanoma: a pitfall in cytological diagnosis. Pathology, 42(3), 287-289. [More Information]
  • Guitera, P., Li, L., Scolyer, R., Menzies, S. (2010). Morphologic Features of Melanophages Under In Vivo Reflectance Confocal Microscopy. Archives of Dermatology, 146(5), 492-498. [More Information]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2010). Non-Sentinel Node Risk Score (N-SNORE): A Scoring System for Accurately Stratifying Risk of Non-Sentinel Node Positivity in Patients With Cutaneous Melanoma With Positive Sentinel Lymph Nodes. Journal of Clinical Oncology, 28(29), 4441-4449. [More Information]
  • Karim, R., Gerega, S., Yang, J., Spillane, A., Carmalt, H., Scolyer, R., Lee, C. (2010). p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours. Histopathology, 56(7), 868-875. [More Information]
  • McCarthy, S., Scolyer, R. (2010). Pitfalls and Important Issues in the Pathologic Diagnosis of Melanocytic Tumors. The Ochsner Journal, 10, 66-74.
  • Murali, R., Shaw, H., McCarthy, S., Quinn, M., Stretch, J., Thompson, J., Scolyer, R. (2010). Prognostic Factors in Cutaneous Desmoplastic Melanoma: A Study of 252 Patients. Cancer, 116(17), 4130-4138. [More Information]
  • Haydu, L., Holt, P., Karim, R., Madronio, C., Thompson, J., Armstrong, B., Scolyer, R. (2010). Quality of histopathological reporting on melanoma and influence of use of a synoptic template. Histopathology, 56(6), 768-774. [More Information]
  • Cadili, A., Dabbs, K., Scolyer, R., Brown, P., Thompson, J. (2010). Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients. Journal of the American College of Surgeons, 211(4), 522-525. [More Information]
  • Lim, C., Cooper, C., Delprado, W., McCarthy, S., Scolyer, R. (2010). Retroperitoneal inflammatory liposarcoma in a patient with non-hodgkin lymphoma: a report highlighting diagnostic pitfalls. Pathology Research International, 2010, 505436. [More Information]
  • Wiener, M., Acland, K., Shaw, H., Soong, S., Li, H., Chen, D., Scolyer, R., Winstanley, J., Thompson, J. (2010). Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model. Annals of Surgical Oncology, 17(8), 1995-2005. [More Information]
  • Barnhill, R., Cerroni, L., Cook, M., Elder, D., Kerl, H., LeBoit, P., McCarthy, S., Mihm, M., Mooi, W., Piepkorn, M., Scolyer, R., et al (2010). State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Advances in Anatomic Pathology, 17(2), 73-90. [More Information]
  • Cooper, C., Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Thompson, J., Scolyer, R. (2010). Synchronous and metachronous malignancies in patients with melanoma: a clinicopathologic study highlighting the role of fine-needle biopsy cytology and potential diagnostic pitfalls. Melanoma Research, 20(3), 203-211. [More Information]
  • Mocellin, S., Shrager, J., Scolyer, R., Pasquali, S., Verdi, D., Marincola, F., Briarava, M., Gobbel, R., Rossi, C., Nitti, D. (2010). Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology. PloS One, 5(8), e11965-1-e11965-11. [More Information]
  • Martiniuk, F., Damian, D., Thompson, J., Scolyer, R., Tchou-Wong, K., Levis, W. (2010). TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. Journal of Drugs in Dermatology: new methods and technology, 9(11), 1368-1372. [More Information]
  • Guitera, P., Pellacani, G., Crotty, K., Scolyer, R., Li, L., Bassoli, S., Vinceti, M., Rabinovitz, H., Longo, C., Menzies, S. (2010). The Impact of In Vivo Reflectance Confocal Microscopy on the Diagnostic Accuracy of Lentigo Maligna and Equivocal Pigmented and Nonpigmented Macules of the Face. Journal of Investigative Dermatology, 130(8), 2080-2091. [More Information]
  • Murali, R., Moncrieff, M., Hong, J., Cooper, C., Shingde, M., Samuel, D., Thompson, J., Scolyer, R. (2010). The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma. Annals of Surgical Oncology, 17(11), 2992-2999. [More Information]
  • Cadili, A., Scolyer, R., Brown, P., Dabbs, K., Thompson, J. (2010). Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma. Annals of Surgical Oncology, 17(11), 3015-3020. [More Information]
  • Murali, R., Scolyer, R. (2010). Tumor-infiltrating lymphocytes and mitotic index in metastatic melanoma as predictors of patient survival. Proceedings of the National Academy of Sciences of the United States of America, 107(13), E46; author reply E47. [More Information]
  • Busam, K., Murali, R., Pulitzer, M., McCarthy, S., Thompson, J., Shaw, H., Brady, M., Coit, D., Dusza, S., Wilmott, J., Scolyer, R., et al (2009). Atypical Spitzoid Melanocytic Tumors With Positive Sentinel Lymph Nodes in Children and Teenagers, and Comparison With Histologically Unambiguous and Lethal Melanomas. American Journal of Surgical Pathology, 33(9), 1386-1395. [More Information]
  • Murali, R., McCarthy, S., Scolyer, R. (2009). Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Advances in Anatomic Pathology, 16(6), 365-382. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2009). Cutaneous melanoma in the era of molecular profiling. The Lancet, 374(9687), 362-365. [More Information]
  • Cooper, C., Danieletto, S., Fong, E., Harris, M., Konya, J., Cooper, W., McCarthy, S., Scolyer, R. (2009). Cutaneous metastasis of epithelioid haemangioendothelioma. Pathology, 41(6), 585-587. [More Information]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2009). Cytological features of melanoma in exfoliative fluid specimens. Journal of Clinical Pathology, 62(7), 638-643. [More Information]
  • Morey, A., Murali, R., McCarthy, S., Mann, G., Scolyer, R. (2009). Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology, 41(4), 383-387. [More Information]
  • Chakera, A., Hesse, B., Burak, Z., Ballinger, J., Britten, A., Caraco, C., Cochran, A., Cook, M., Drzewiecki, K., Scolyer, R., Thompson, J., Uren, R., et al (2009). EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. European Journal of Nuclear Medicine and Molecular Imaging, 36(10), 1713-1742. [More Information]
  • Hare, D., Burger, F., Austin, C., Fryer, F., Grimm, R., Reedy, B., Scolyer, R., Thompson, J., Doble, P. (2009). Elemental bio-imaging of melanoma in lymph node biopsies. The Analyst, 134(3), 450-453. [More Information]
  • Orlow, I., Tommasi, D., Bloom, B., Ostrovnaya, I., Cotignola, J., Mujumdar, U., Busam, K., Jungbluth, A., Scolyer, R., Thompson, J., Armstrong, B., et al (2009). Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling. Journal of Investigative Dermatology, 129(8), 1972-1982. [More Information]
  • Zhuang, L., Scolyer, R., Lee, C., McCarthy, S., Cooper, W., Zhang, X., Thompson, J., Hersey, P. (2009). Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology, 54(4), 462-470. [More Information]
  • Lam, T., Uren, R., Scolyer, R., Shannon, K., Thompson, J. (2009). False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Research, 19(2), 94-99. [More Information]
  • Narita, N., Tanemura, A., Murali, R., Scolyer, R., Huang, S., Arigami, T., Yanagita, S., Chong, K., Thompson, J., Morton, D., et al (2009). Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene, 28(34), 3058-3068. [More Information]
  • Tse, G., Lui, P., Vong, J., Yu, A., Putti,, T., Karim, R., Scolyer, R., Lee, C., Ng, D., Tse, A., et al (2009). Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Research and Treatment, 114(3), 441-448. [More Information]
  • Murali, R., Cochran, A., Cook, M., Hillman, J., Karim, R., Moncrieff, M., Starz, H., Thompson, J., Scolyer, R. (2009). Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer, 115(21), 5026-5037. [More Information]
  • Murali, R., Hughes, M., FitzGerald, P., Thompson, J., Scolyer, R. (2009). Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma. Annals of Surgery, 249(4), 641-647. [More Information]
  • Huang, S., Darfler, M., Nicholl, M., You, J., Bemis, K., Tegeler, T., Wang, M., Wery, J., Chong, K., Scolyer, R., et al (2009). LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PloS One, 4(2), e4430-1-e4430-12. [More Information]
  • Karim, R., Gerega, S., Yang, J., Spillane, A., Carmalt, H., Scolyer, R., Lee, C. (2009). Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. The Breast, 18(3), 165-170. [More Information]
  • Mandal, R., Murali, R., Lundquist, K., Ragsdale, B., Heenan, P., McCarthy, S., Mihm, M., Scolyer, R., Zembowicz, A. (2009). Pigmented Epithelioid Melanocytoma: Favorable Outcome After 5-year Follow-up. American Journal of Surgical Pathology, 33(12), 1778-1782. [More Information]
  • Shingde, M., Buckland,, M., Busam, K., McCarthy, S., Wilmott, J., Thompson, J., Scolyer, R. (2009). Primary cutaneous Ewing sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis. Journal of Clinical Pathology, 62(10), 915-919. [More Information]
  • Spillane, A., Cheung, B., Stretch, J., Scolyer, R., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2009). Proposed quality standards for regional lymph node dissections in patients with melanoma. Annals of Surgery, 249(3), 473-480. [More Information]
  • Karim, R., Gerega, S., Yang, J., Horvath, L., Spillane, A., Carmalt, H., Scolyer, R., Lee, C. (2009). Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours. Journal of Clinical Pathology, 62(11), 1016-1020. [More Information]
  • Gzell, C., Carroll, S., Suchowerska, N., Beith, J., Tan, K., Scolyer, R. (2009). Radiation recall dermatitis after pre-sensitization with pegylated liposomal doxorubicin. Cancer Investigation, 27(4), 397-401. [More Information]
  • Karim, R., Li, W., Sanki, A., Colman, M., Yang, J., Thompson, J., Scolyer, R. (2009). Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. International Journal of Surgical Pathology, 17(5), 361-367. [More Information]
  • Howman-Giles, R., Shaw, H., Scolyer, R., Murali, R., Wilmott, J., McCarthy, S., Uren, R., Thompson, J. (2009). Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients. Annals of Surgical Oncology, 17(1), 138-143. [More Information]
  • Mocellin, S., Thompson, J., Pasquali, S., Montesco, M., Pilati, P., Nitti, D., Saw, R., Scolyer, R., Stretch, J., Rossi, C. (2009). Sentinel Node Status Prediction by Four Statistical Models Results From a Large Bi-Institutional Series (n=1132). Annals of Surgery, 250(6), 964-969. [More Information]
  • Martin, R., Murali, R., Scolyer, R., FitzGerald, P., Colman, M., Thompson, J. (2009). So-called "malignant blue nevus": a clinicopathologic study of 23 patients. Cancer, 115(13), 2949-2955. [More Information]
  • Sanki, A., Scolyer, R., Thompson, J. (2009). Surgery for melanoma metastases of the gastrointestinal tract: Indications and results. European Journal of Surgical Oncology, 35, 313-319. [More Information]
  • Sanki, A., Uren, R., Moncrieff, M., Tran, K., Scolyer, R., Lin, H., Thompson, J. (2009). Targeted High-Resolution Ultrasound Is Not an Effective Substitute for Sentinel Lymph Node Biopsy in Patients With Primary Cutaneous Melanoma. Journal of Clinical Oncology, 27(22), 5614-5619. [More Information]
  • Becker, T., Haferkamp, S., Dijkstra, M., Scurr, L., Frausto, M., Diefenbach, E., Scolyer, R., Reisman, D., Mann, G., Kefford, R., Rizos, H. (2009). The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Molecular Cancer, 8(4), 4-1-4-12. [More Information]
  • Amersi, F., Terando, A., Goto, Y., Scolyer, R., Thompson, J., Tran, A., Faries, M., Morton, D., Hoon, D. (2008). Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clinical Cancer Research, 14(3), 638-645. [More Information]
  • Van Es, S., Colman, M., Thompson, J., McCarthy, S., Scolyer, R. (2008). Angiotropism is an Independent Predictor of Local Recurrence and In-transit Metastasis in Primary Cutaneous Melanoma. American Journal of Surgical Pathology, 32(9), 1396-403. [More Information]
  • Beavis, A., Dawson, M., Doble, P., Scolyer, R., Bourne, R., Li, L., Murali, R., Stretch, J., Lean, C., Uren, R., Thompson, J. (2008). Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma-Mass Spectrometry. Annals of Surgical Oncology, 15(3), 934-940. [More Information]
  • Moncrieff, M., Scolyer, R., Thompson, J., Beavis, A., Uren, R., Stretch, J. (2008). Correct identification of a sentinel node postselective lymphadenectomy using antimony levels. Melanoma Research, 18(5), 365-366. [More Information]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2008). Cytologic Features of Metastatic and Recurrent Melanoma in Patients With Primary Cutaneous Desmoplastic Melanoma. American Journal of Clinical Pathology, 130(5), 715-723. [More Information]
  • Chen, J., Hruby, G., Scolyer, R., Murali, R., Hong, A., FitzGerald, P., Pham, T., Quinn, M., Thompson, J. (2008). Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer, 113(10), 2770-2778. [More Information]
  • Doubrovsky, A., Scolyer, R., Murali, R., McKenzie, P., Watson, G., Lee, C., McLeod, D., McCarthy, W., Uren, R., Stretch, J., Saw, R., Thompson, J. (2008). Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management. Annals of Surgical Oncology, 15(1), 323-332. [More Information]
  • Shipman, A., Agero, A., Cook, I., Scolyer, R., Craig, P., Pas, H., Wojnarowska, F., Murrell, D. (2008). Epidermolysis bullosa acquisita requiring multiple oesophageal dilatations. Clinical and Experimental Dermatology, 33(6), 787-9. [More Information]
  • Karim, R., Scolyer, R., Li, W., Yee, V., McKinnon, J., Li, L., Uren, R., Lam, S., Beavis, A., Dawson, M., Thompson, J., et al (2008). False Negative Sentinel Lymph Node Biopsies in Melanoma May Result From Deficiencies in Nuclear Medicine, Surgery, or Pathology. Annals of Surgery, 247(6), 1003-1010. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2008). Fine-needle biopsy as a diagnostic technique for metastatic melanoma. Expert Opinion on Medical Diagnostics, 2, 1-10.
  • Moncrieff, M., Kroon, H., Kam, P., Stalley, P., Scolyer, R., Thompson, J. (2008). Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity. Annals of Surgical Oncology, 15(10), 2749-2756. [More Information]
  • Warner, R., Quinn, M., Hruby, G., Scolyer, R., Uren, R., Thompson, J. (2008). Management of Merkel Cell Carcinoma: The Roles of Lymphoscintigraphy, Sentinel Lymph Node Biopsy and Adjuvant Radiotherapy. Annals of Surgical Oncology, 15(9), 2509-2518. [More Information]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2008). Pathologic examination of sentinel lymph nodes from melanoma patients. Seminars in Diagnostic Pathology, 25(2), 100-111. [More Information]
  • Shaw, H., Scolyer, R., Thompson, J. (2008). Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology, 53(3), 345. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2008). Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. Future Oncology, 4(4), 535-551. [More Information]
  • Karim, R., van den Berg, K., Colman, M., McCarthy, S., Thompson, J., Scolyer, R. (2008). The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology, 52(2), 130-138. [More Information]
  • Scolyer, R., Murali, R., Satzger, I., Thompson, J. (2008). The detection and significance of melanoma micrometastases in sentinel nodes. Surgical oncology, 17(3), 165-174. [More Information]
  • O'Brien, P., Davies, M., Scurry, J., Smith, A., Barton, C., Henderson, M., Saunders, D., Gloss, B., Patterson, K., et, A., Murali, R., Scolyer, R., Scurr, L., deFazio, A. (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6), 1085-1093. [More Information]
  • Gray, A., Scolyer, R. (2008). The economic analyses of the UK prospective diabetes study. Diabetic Medicine, 25(Suppl. 2), 47-57. [More Information]
  • Thompson, J., Shaw, H., Scolyer, R. (2008). The Prognostic Significance of Isolated Immunohistochemically Positive Cells in Sentinel Lymph Nodes of Melanoma Patients. The American Journal of Surgical Pathology, 32(7), 1106-7; author reply 1107-8. [More Information]
  • Tan, K., Scolyer, R., McCarthy, S., Schatz, J., Nabarro, M., Lee, K., Rusli, J., Banu, B., Fiona Bonar, S. (2008). Tumoural calcium pyrophosphate dihydrate crystal deposition disease (tophaceous pseudogout) of the hand: a report of two cases including one with a previously unreported associated florid reactive myofibroblastic proliferation. Pathology, 40(7), 719-22. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R., Uren, R. (2007). (Letter to the Editor) Melanoma Management in 2007. Australian Family Physician, 36(7), 487-488. [More Information]
  • Tan, K., Thompson, J., Arnold, C., McCarthy, S., Scolyer, R. (2007). Current perspectives on the pathologic diagnosis and reporting of melanocytic tumors. Giornale Italiano di Dermatologia e Venereologia, 142, 83-97.
  • Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Lee, C., McLeod, D., Uren, R., Stretch, J., Saw, R., Thompson, J., Scolyer, R. (2007). Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. American Journal of Clinical Pathology, 127(3), 385. [More Information]
  • Tse, G., Chaiwun, B., Lau, K., Scolyer, R., Lee, C., Karim, R., Putti, T., Law, B., Lui, P., Tan, P. (2007). Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours. Journal of Clinical Pathology, 60(9), 1051-1056. [More Information]
  • Elliott, B., Scolyer, R., Suciu, S., Lebecque, S., Rimoldi, D., Gugerli, O., Musat, E., Sharma, R., Lienard, D., Keilholz, U., Thompson, J., et al (2007). Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. Clinical Cancer Research, 13(13), 3825-3830. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Hersey, P., Thompson, J., Zhang, X. (2007). Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Modern Pathology, 20(4), 416-426. [More Information]
  • Jabbour, J., Cumming, R., Scolyer, R., Hruby, G., Thompson, J., Lee, S. (2007). Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease-Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004. Annals of Surgical Oncology, 14(6), 1943-1952. [More Information]
  • Li, W., Tran, N., Lee, C., O'Brien, C., Tse, G., Scolyer, R., Hong, A., Milross, C., Yu, K., Rose, B. (2007). New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis. Pathology, 39(2), 217-222. [More Information]
  • Scolyer, R., Thompson, J. (2007). Primary melanoma of the lung. The American surgeon, 73(9), 937-938. [More Information]
  • Shaw, H., Scolyer, R., Thompson, J. (2007). Re: NM patients and SN. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 5(5), 320. [More Information]
  • Sanki, A., Li, W., Colman, M., Karim, R., Thompson, J., Scolyer, R. (2007). Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma. Pathology, 39(6), 551-557. [More Information]
  • Murali, R., Sharma, R., Thompson, J., Stretch, J., Lee, C., McCarthy, S., Scolyer, R. (2007). Sentinel Lymph Node Biopsy in Histologically Ambiguous Melanocytic Tumors With Spitzoid Features (So-Called Atypical Spitzoid Tumors). Annals of Surgical Oncology, 15(1), 302-309. [More Information]
  • Tan, K., Moncrieff, M., Thompson, J., McCarthy, S., Shaw, H., Quinn, M., Li, L., Crotty, K., Stretch, J., Scolyer, R. (2007). Subungual Melanoma: A Study of 124 Cases Highlighting Features of Early Lesions, Potential Pitfalls in Diagnosis, and Guidelines for Histologic Reporting. American Journal of Surgical Pathology, 31(12), 1902-1912. [More Information]
  • Sassen, S., Shaw, H., Colman, M., Scolyer, R., Thompson, J. (2007). The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center. Annals of Surgical Oncology, 15(2), 630-637. [More Information]
  • Scolyer, R., Thompson, J., Shaw, H., McCarthy, S. (2007). The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma. Journal Of Cutaneous Pathology, 33(5), 395-396. [More Information]
  • Heinzelmann-Schwarz, V., Gardiner-Garden, M., Henshall, S., Scurry, J., Scolyer, R., Smith, A., Bali, A., Vanden Bergh, P., Baron-Hay, S., Scott, C., et al (2006). A distinct molecular profile associated with mucinous epithelial ovarian cancer. British Journal of Cancer, 94(6), 904-913. [More Information]
  • Bonar, S., Viglione, W., Schatz, J., Scolyer, R., McCarthy, S. (2006). An unusual variant of intraneural ganglion of the common peroneal nerve. Skeletal Radiology, 35(3), 165-71. [More Information]
  • Maclean, F., Schatz, J., McCarthy, S., Scolyer, R., Stalley, P., Bonar, S. (2006). Epithelioid and spindle cell haemangioma of bone. Skeletal Radiology, 36, S50-7. [More Information]
  • Heinzelmann-Schwarz, V., Scolyer, R., Scurry, J., Smith, A., Gardiner-Garden, M., Biankin, A., Baron-Hay, S., Scott, C., Ward, R., Fink, D., et al (2006). Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries. Journal of Clinical Pathology, 60(6), 622-626. [More Information]
  • Dray, M., McCarthy, S., Palmer, A., Bonar, S., Stalley, P., Marjoniemi, V., Millar, E., Scolyer, R. (2006). Myopericytoma: a unifying term for a spectrum of tumours that show overlapping features with myofibroma. A review of 14 cases. Journal of Clinical Pathology, 59(1), 67-73. [More Information]
  • Karim, R., Wills, E., McCarthy, S., Scolyer, R. (2006). Myxoid variant of adrenocortical carcinoma: report of a unique case. Pathology international, 56(2), 89-94. [More Information]
  • Pua, V., Scolyer, R., Barnetson, R. (2006). Pravastatin-induced lichenoid drug eruption. Australasian Journal of Dermatology, 47(1), 57-59. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Zhang, X., Thompson, J., Screaton, G., Hersey, P. (2006). Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Human Pathology, 37(10), 1286-1294. [More Information]
  • Ashford, R., McCarthy, S., Scolyer, R., Bonar, S., Karim, R., Stalley, P. (2006). Surgical biopsy with intra-operative frozen section: AN ACCURATE AND COST-EFFECTIVE METHOD FOR DIAGNOSIS OF MUSCULOSKELETAL SARCOMAS. Journal of Bone and Joint Surgery: British Volume, 88(9), 1207-1211. [More Information]
  • Thompson, J., Scolyer, R., Uren, R. (2006). Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surgical Oncology Clinics of North America, 15(2), 301-18. [More Information]
  • Shaw, H., Quinn, M., Scolyer, R., Thompson, J. (2006). Survival in patients with desmoplastic melanoma. Journal of Clinical Oncology, 24(8), e12-e12. [More Information]
  • Li, W., Sanki, A., Karim, R., Thompson, J., Soon, L., Zhuang, L., McCarthy, S., Scolyer, R. (2006). The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology, 38(4), 287-301. [More Information]
  • van Poll, D., Thompson, J., Colman, M., McKinnon, J., Saw, R., Stretch, J., Scolyer, R., Uren, R. (2005). A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(8), 597-608. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Palmer, A., Zhang, X., Thompson, J., Bron, L., Hersey, P. (2005). Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. Journal of Clinical Pathology, 58(11), 1163-1169. [More Information]
  • Armour, K., Scolyer, R., Barnetson, R. (2005). Borderline lepromatous leprosy presenting as a single cutaneous plaque. Australasian Journal of Dermatology, 46(3), 181-183. [More Information]
  • Karim, R., Rose, B., Brammah, S., Scolyer, R. (2005). Condylomata acuminata of the urinary bladder with HPV 11. Pathology, 37(2), 176-178. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2005). Cutaneous melanoma. The Lancet, 365(9460), 687-701. [More Information]
  • Scolyer, R., Thompson, J. (2005). Desmoplastic melanoma: a heterogeneous entity in which subclassification as pure" or "mixed" may have important prognostic significance.". Annals of Surgical Oncology, 12(3), 197-9. [More Information]
  • Kim, Y., Scolyer, R., Chia, E., Steven, D., Ghabrial, R. (2005). Eccrine porocarcinoma of the upper eyelid. The Australasian Journal of Dermatology, 46(4), 278-81. [More Information]
  • Bron, L., Scolyer, R., Thompson, J., Hersey, P. (2005). Histological expression of tumour necrosis factor-related apotosis-induced ligand (TRAIL) in human primary melanoma. Pathology, 36(6), 561-565. [More Information]
  • McKinnon, J., Starritt, E., Scolyer, R., McCarthy, W., Thompson, J. (2005). Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick. Annals of Surgery, 241(2), 326-333. [More Information]
  • Bourne, R., Stanwell, P., Stretch, J., Scolyer, R., Thompson, J., Mountford, C., Lean, C. (2005). In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. European Journal of Radiology, 53(3), 506-513. [More Information]
  • Scolyer, R., Thompson, J., McCarthy, S., Gershenwald, J., Ross, M., Cochran, A. (2005). Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. Journal of the American College of Surgeons, 201(5), 821-3; author reply 823-4. [More Information]
  • de Wilt, J., Farmer, S., Scolyer, R., McCaughan, B., Thompson, J. (2005). Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour? Melanoma Research, 15(6), 531-537. [More Information]
  • Stretch, J., Thompson, J., Scolyer, R., Mountford, C., Lean, C. (2005). Magnetic resonance spectroscopy in the management of melanoma. Cancer Forum, 29(2), 73-76.
  • Stretch, J., Somorjai, R., Bourne, R., Hsiao, E., Scolyer, R., Dolenko, B., Thompson, J., Mountford, C., Lean, C. (2005). Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples. Annals of Surgical Oncology, 12(11), 943-949. [More Information]
  • Yee, V., Thompson, J., McKinnon, J., Scolyer, R., Li, L., McCarthy, W., O'Brien, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R. (2005). Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Annals of Surgical Oncology, 12(6), 429-439. [More Information]
  • Thompson, J., Uren, R., Stretch, J., Scolyer, R. (2005). Selective sentinel lymphadenectomy: progress to date and prospects for the future. Cancer Treatment and Research, 127(Supplement), 269-287. [More Information]
  • Tse, G., Tsang, A., Putti, T., Scolyer, R., Lui, P., Law, B., Karim, R., Lee, C. (2005). Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours. Journal of Clinical Pathology, 58(2), 185-189. [More Information]
  • Tse, G., Wong, F., Tsang, A., Lee, C., Lui, P., Lo, A., Law, B., Scolyer, R., Karim, R., Putti, T. (2005). Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. Journal of Clinical Pathology, 58(6), 600-604. [More Information]
  • Weber, F., Byrne, S., Le, S., Brown, D., Breit, S., Scolyer, R., Halliday, G. (2005). Transforming growth factor-b1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system. Cancer Immunology, Immunotherapy: other biological response modifications, 54(9), 898-906. [More Information]
  • Starritt, E., Uren, R., Scolyer, R., Quinn, M., Thompson, J. (2005). Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(1), 18-23. [More Information]
  • Scolyer, R., Thompson, J., Li, L., Beavis, A., Dawson, M., Doble, P., Soper, R., Uren, R., Stretch, J., Sharma, R., et al (2004). Antimony Concentrations In Nodal Tissue Can Confirm Sentinel Node Identity. Modern Pathology, 17(10), 1191-1197.
  • Scolyer, R., Zhuang, L., Palmer, A., Thompson, J., McCarthy, S. (2004). Combined Naevus: A Benign Lesion Frequently Misdiagnosed Both Clinically And Pathologically As Melanoma. Pathology, 36(5), 419-427.
  • Thompson, J., Scolyer, R. (2004). Cooperation Between Surgical Oncologists And Pathologists: A Key Element Of Multidisciplinary Care For Patients With Cancer. Pathology, 36(5), 496-503.
  • de Wilt, J., Thompson, J., Uren, R., Ka, V., Scolyer, R., McCarthy, W., O'Brien, C., Quinn, M., Shannon, K. (2004). Correlation Between Preoperative Lymphoscintigraphy And Metastatic Nodal Disease Sites In 362 Patients With Cutaneous Melanomas Of The Head And Neck. Annals of Surgery, 239(4), 544-552.
  • Sarris, M., Scolyer, R., Konopka, M., Thompson, J., Harper, C., Lee, S. (2004). Cytoplasmic Expression Of Nm23 Predicts The Potential For Cerebral Metastasis In Patients With Primary Cutaneous Melanoma. Melanoma Research, 14(1), 23-27.
  • McCarthy, S., Scolyer, R., Palmer, A. (2004). Desmoplastic Melanoma: A Diagnostic Trap For The Unwary. Pathology, 36(5), 445-451.
  • Scolyer, R., Thompson, J., Li, L., Beavis, A., Dawson, M., Doble, P., Ka, V., McKinnon, J., Soper, R., Uren, R., Shaw, H., Stretch, J., McCarthy, S. (2004). Failure To Remove True Sentinel Nodes Can Cause Failure Of The Sentinel Node Biopsy Technique: Evidence From Antimony Concentrations In False-Negative Sentinel Nodes From Melanoma Patients. Annals of Surgical Oncology, 11(Supplement 3), 174S-178S.
  • Bron, L., Scolyer, R., Thompson, J., Hersey, P. (2004). Histological Expression Of Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) In Human Primary Melanoma. Pathology, 36(6), 561-565.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2004). Immunohistochemical Stains Fail To Increase The Detection Rate Of Micrometastatic Melanoma In Completion Regional Lymph Node Dissection Specimens. Melanoma Research, 14(4), 263-268.
  • Tse, G., Putti, T., Lui, P., Lo, A., Scolyer, R., Law, B., Karim, R., Lee, C. (2004). Increased C-Kit (Cd117) Expression In Malignant Mammary Phyllodes Tumors. Modern Pathology, 17(7), 827-831.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2004). Micromorphometric Features Of Positive Sentinel Lymph Nodes Predict Involvement Of Nonsentinel Nodes In Patients With Melanoma. American Journal of Clinical Pathology, 122(4), 532-539.
  • Karim, R., Ma-Wyatt, J., Cox, M., Scolyer, R. (2004). Myoid Angioendothelioma Of The Spleen. International Journal of Surgical Pathology, 12(1), 51-56.
  • Heinzelmann-Schwarz, V., Gardiner-Garden, M., Henshall, S., Scurry, J., Scolyer, R., Davies, M., Heinzelmann, M., Kalish, L., Bali, A., Kench, J., et al (2004). Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clinical Cancer Research, 10(13), 4427-4436. [More Information]
  • Scolyer, R., Bonar, S., Palmer, A., Barr, E., Wills, E., Stalley, P., Schatz, J., Soper, J., Li, L., McCarthy, S. (2004). Parachordoma Is Not Distinguishable From Axial Chordoma Using Immunohistochemistry. Pathology international, 54(5), 364-370.
  • Scolyer, R., Thompson, J., Stretch, J., Sharma, R., McCarthy, S. (2004). Pathology Of Melanocytic Lesions: New, Controversial, And Clinically Important Issues. Journal of Surgical Oncology, 86(4), 200-211. [More Information]
  • Zborowska, B., Ell, J., McGee-Collett, M., Scolyer, R., McCluskey, P. (2004). Progressive visual loss in a patient with presumed temporal arteritis despite treatment: how to make the diagnosis. Clinical and Experimental Ophthalmology, 32, 335-336.
  • Thompson, J., Stretch, J., Uren, R., Ka, V., Scolyer, R. (2004). Sentinel Node Biopsy For Melanoma: Where Have We Been And Where Are We Going? Annals of Surgical Oncology, 11(Supplement 3), 147S-151S.
  • Doubrovsky, A., De Wilt, J., Scolyer, R., McCarthy, W., Thompson, J. (2004). Sentinel Node Biopsy Provides More Accurate Staging Than Elective Lymph Node Dissection In Patients With Cutaneous Melanoma. Annals of Surgical Oncology, 11(9), 829-836.
  • Tse, G., Lui, P., Lee, C., Kung, F., Scolyer, R., Law, B., Lau, T., Karim, R., Putti, T. (2004). Stromal Expression Of Vascular Endothelial Growth Factor Correlates With Tumor Grade And Microvessel Density In Mammary Phyllodes Tumors: A Multicenter Study Of 185 Cases. Human Pathology, 35(9), 1053-1057. [More Information]
  • Li, W., Thompson, C., Cossart, Y., O'Brien, C., McNeil, E., Scolyer, R., Rose, B. (2004). The Expression Of Key Cell Cycle Markers And Presence Of Human Papillomavirus In Squamous Cell Carcinoma Of The Tonsil. Head and Neck, 26(1), 1-9. [More Information]
  • Haviv, M., Scolyer, R. (2004). The First Laurent Series Coefficients For Singularly Perturbed Stochastic Matrices'. Linear Algebra and its Applications, 386, 243-259.
  • Thompson, J., Shaw, H., Hersey, P., Scolyer, R. (2004). The History And Future Of Melanoma Staging. Journal of Surgical Oncology, 86(4), 224-235. [More Information]
  • Francken, A., Shaw, H., Thompson, J., Soong, S., Accortt, N., Azzola, M., Scolyer, R., Milton, G., McCarthy, W., Colman, M., et al (2004). The Prognostic Importance Of Tumor Mitotic Rate Confirmed In 1317 Patients With Primary Cutaneous Melanoma And Long Follow-Up. Annals of Surgical Oncology, 11(4), 426-433.
  • Karim, R., Tse, G., Putti, T., Scolyer, R., Lee, C. (2004). The Significance Of The Wnt Pathway In The Pathology Of Human Cancers. Pathology, 36(2), 120-128.
  • Li, W., Thompson, C., Cossart, Y., O'Brien, C., Liu, J., Scolyer, R., Carter, J., Dalrymple, C., Rose, B. (2004). The Site Of Infection And Ethnicity Of The Patient Influence The Biological Pathways To Hpv-Induced Mucosal Cancer. Modern Pathology, 17(9), 1031-1037.
  • Wells, J., Kosky, C., Scolyer, R., Lee, S., Bye, P., Young, G., Davies, L. (2004). Unusual Case Of Subcutaneous Panniculitis-Like T-Cell Lymphoma. Australasian Journal of Dermatology, 45(2), 114-118. [More Information]
  • Abe, K., Abe, K., Abe, T., Adachi, I., Scolyer, R., Aihara, H., Akai, K., Akatsu, M., Akemoto, M., Asano, Y., Bakich, A., Parslow, N., et al (2004). Upper Bound On The Decay Tau ->Mu Gamma From The Belle Detector. Physical Review Letters, 92(17), 171802-1-171802-6.
  • Stewart, M., Scolyer, R. (2004). User Needs Analysis And Development Of Priorities For Life Cycle Impact Assessment. International Journal of Life Cycle Assessment, 9(3), 153-160.
  • Li, W., Thompson, C., Xin, D., Cossart, Y., O'Brien, C., McNeil, E., Gao, K., Scolyer, R., Rose, B. (2003). Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. The American Journal of Pathology: cellular and molecular biology of disease, 163(6), 2185-2189.
  • Dawson, M., Doble, P., Beavis, A., Li, L., Soper, R., Scolyer, R., Uren, R., Thompson, J. (2003). Antimony by ICP-MS as a marker for sentinel lymphnodes in melanoma patients. The Analyst, 128(3), 217-219.
  • Li, L., Crotty, K., Palmer, A., Kril, J., Scolyer, R., Thompson, J., Li, L., McCarthy, S. (2003). Argyrophilic staining of nucleolar organizer region count and morphometry in benign and melignant melanocytic lesions. American Journal Of Dermatopathology, 25(3), 190-197.
  • Li, W., Thompson, C., O'Brien, C., McNeil, E., Scolyer, R., Cossart, Y., Veness, M., Walker, D., Morgan, G., Rose, B. (2003). Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. International Journal of Cancer, 106(4), 553-558. [More Information]
  • Slater, M., Scolyer, R., Gidley-Baird, A., Thompson, J., Barden, J. (2003). Increased expression of apoptotic markers in melanoma. Melanoma Research, 13(2), 137-145.
  • Scolyer, R., Shaw, H., Thompson, J., Li, L., Colman, M., Lo, S., McCarthy, S., Palmer, A., Nicoll, K., Dutta, B., Stretch, J., et al (2003). Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. American Journal of Surgical Pathology, 27(12), 1571-1576.
  • Li, L., Scolyer, R., Ka, V., McKinnon, J., Shaw, H., McCarthy, S., Thompson, J. (2003). Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional Recurrence: A Clinicopathologic Study of 1152 Patients Undergoing Sentinel Lymph Node Biopsy. American Journal of Surgical Pathology, 27(9), 1197-1202.
  • Lean, C., Bourne, R., Thompson, J., Scolyer, R., Stretch, J., Li, L., Russell, P., Mountford, C. (2003). Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biospy specimens. Melanoma Research, 13(3), 259-261.
  • Azzola, M., Shaw, H., Thompson, J., Soong, S., Scolyer, R., Watson, G., Colman, M., Zhang, Y. (2003). Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: An analysis of 3661 patients from a single center. Cancer, 97(6), 1488-1498. [More Information]
  • Li, L., Crotty, K., Scolyer, R., Thompson, J., Kril, J., Palmer, A., McCarthy, S. (2003). Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyophilic staining of nucleolar organizer regions and MIBI1-Ki67 immunoreactivity. Melanoma Research, 13(6), 581-586.
  • Li, L., Crotty, K., Palmer, A., Kril, J., Stankovic, R., Scolyer, R., McCarthy, S. (2002). Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation. Analytical and Quantitative Cytology and Histology, 24(4), 234-243.
  • Tse, G., Soon, L., Kung, F., Scolyer, R., Law, B., Lau, T., Putti, T. (2002). Hormonal Receptors Expression in Epithelial Cells of Mammary Phyllodes Tumors Correlates with Pathologic Grade of the Tumor A Multicenter Study of 143 Cases. American Journal of Clinical Pathology, 118(4), 522-526.
  • Li, L., Crotty, K., Palmer, A., Kril, J., Scolyer, R., McCarthy, S. (2002). Melanin bleaching in argyrophilic staining of agNORs in pigmented lesions. Analytical and Quantitative Cytology and Histology, 24(3), 166-172.
  • Lee, C., Scolyer, R., McKenzie,, P., Achmed, D. (2001). Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology? Pathology, 33, 437-443.
  • Scolyer, R., McKenzie, P., Achmed, D., Lee, C. (2001). Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology? Pathology, 1, 2389-2392.
  • Harper, C., Buckland,, M., Scolyer, R., Donellan, M., Brew, S., McGee-Collett, M. (2001). Spinal chloroma presenting with triplegia in an aleukaemic patient. Pathology, 33, 386-389.

2015

  • Jayawardana, K., Schramm, S., Haydu, L., Thompson, J., Scolyer, R., Mann, G., Muller, S., Yang, J. (2015). Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information. International Journal of Cancer, 136(4), 863-874. [More Information]

2014

  • Dutton-Regester, K., Gartner, J., Emmanuel, R., Qutob, N., Davies, M., Gershenwald, J., Robinson, W., Robinson, S., Rosenberg, S., Scolyer, R., Mann, G., Thompson, J., et al (2014). A highly recurrent RPS27 5'UTR mutation in melanoma. Oncotarget, 5(10), 2912-2917.
  • Vilain, R., Wilmott, J., Scolyer, R. (2014). A light shines on melanoma metastagenesis. Pigment Cell & Melanoma Research, 25(7), 696-697. [More Information]
  • Shi, H., Hong, A., Kong, X., Koya, R., Song, C., Moriceau, G., Hugo, W., Yu, C., Ng, C., Chodon, T., Scolyer, R., Kefford, R., Long, G., et al (2014). A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition. Cancer Discovery, 4(1), 69-79. [More Information]
  • Wouters, J., Stas, M., Govaere, O., Barrette, K., Dudek, A., Vankelecom, H., Haydu, L., Thompson, J., Scolyer, R., van den Oord, J. (2014). A novel hypoxia-associated subset of FN1(high)MITF(low) melanoma cells: identification, characterization, and prognostic value. Modern Pathology, 27(8), 1088-1100. [More Information]
  • McCormack, C., Conyers, R., Scolyer, R., Kirkwood, J., Speakman, D., Wong, N., Kelly, J., Henderson, M. (2014). Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy. Melanoma Research, 24(5), 437-447. [More Information]
  • Rizos, H., Menzies, A., Pupo, G., Carlino, M., Fung, C., Hyman, J., Haydu, L., Mijatov, B., Becker, T., Boyd, S., Howle, J., Saw, R., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2014). BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact. Clinical Cancer Research, 20(7), 1965-1977. [More Information]
  • Kakavand, H., Crainic, O., Lum, T., O'Toole, S., Kefford, R., Thompson, J., Wilmott, J., Long, G., Scolyer, R. (2014). Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas. Pathology, 46(3), 193-198. [More Information]
  • Carlino, M., Haydu, L., Kakavand, H., Menzies, A., Hamilton, A., Yu, B., Ng, C., Cooper, W., Thompson, J., Kefford, R., O'Toole, S., Scolyer, R., Long, G. (2014). Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma. British Journal of Cancer, 111(2), 292-299. [More Information]
  • Sebaratnam, D., Martin, L., Venugopal, S., Mangos, G., Freiman, J., de Souza, P., Farnsworth, A., Cheung, K., Scolyer, R., Murrell, D. (2014). Diffuse melanosis cutis in the setting of BRAFV 600 E metastatic melanoma. International Journal Of Dermatology, 53(11), 1409-1411. [More Information]
  • Marzese, D., Scolyer, R., Roqué, M., Vargas-Roig, L., Huynh, J., Wilmott, J., Murali, R., Buckland, M., Barkhoudarian, G., Thompson, J., et al (2014). DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations. Neuro-Oncology, 16(11), 1499-1509. [More Information]
  • Wilmott, J., Haydu, L., Menzies, A., Lum, T., Hyman, J., Thompson, J., Hersey, P., Kefford, R., Scolyer, R., Long, G. (2014). Dynamics of chemokine, cytokine, and growth factor serum levels in BRAF-mutant melanoma patients during BRAF inhibitor treatment. The Journal of Immunology, 192(5), 2505-2513. [More Information]
  • Marzese, D., Scolyer, R., Huynh, J., Huang, S., Hirose, H., Chong, K., Kiyohara, E., Wang, J., Kawas, N., Donovan, N., Buckland, M., Thompson, J., et al (2014). Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Human Molecular Genetics, 23(1), 226-238. [More Information]
  • Lezcano, C., Lee, C., Larson, A., Menzies, A., Kefford, R., Thompson, J., Mihm, M., Ogino, S., Long, G., Scolyer, R., et al (2014). Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors. Modern Pathology, 27(9), 1193-1202. [More Information]
  • Griewank, K., Scolyer, R., Thompson, J., Flaherty, K., Schadendorf, D., Murali, R. (2014). Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects. Journal of the National Cancer Institute, 106(2), 1-17. [More Information]
  • Griewank, K., van de Nes, J., Schilling, B., Moll, I., Sucker, A., Kakavand, H., Haydu, L., Asher, M., Zimmer, L., Hillen, U., Thompson, J., Scolyer, R., et al (2014). Genetic and clinico-pathologic analysis of metastatic uveal melanoma. Modern Pathology, 27(2), 175-183. [More Information]
  • Gerami, P., Busam, K., Cochran, A., Cook, M., Duncan, L., Elder, D., Fullen, D., Guitart, J., LeBoit, P., Mihm, M., Scolyer, R., et al (2014). Histomorphologic Assessment and Interobserver Diagnostic Reproducibility of Atypical Spitzoid Melanocytic Neoplasms With Long-term Follow-up. The American Journal of Surgical Pathology, 38(7), 934-940. [More Information]
  • Zimmer, L., Haydu, L., Menzies, A., Scolyer, R., Kefford, R., Thompson, J., Schadendorf, D., Long, G. (2014). Incidence of New Primary Melanomas After Diagnosis of Stage III and IV Melanoma. Journal of Clinical Oncology, 32(8), 816-823. [More Information]
  • Long, G., Fung, C., Menzies, A., Pupo, G., Carlino, M., Hyman, J., Shahheydari, H., Tembe, V., Thompson, J., Saw, R., Howle, J., Scolyer, R., Kefford, R., Rizos, H., et al (2014). Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma. Nature Communications, 5, 1-9. [More Information]
  • Gopal, V., Rizos, H., Chen, G., Deng, W., Frederick, D., Cooper, Z., Scolyer, R., Pupo, G., Komurov, K., Sehgal, V., Long, G., et al (2014). Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma. Cancer Research, 74(23), 7037-7047. [More Information]
  • Menzies, A., Wilmott, J., Long, G., Scolyer, R. (2014). Intra-patient heterogeneity of BRAF mutation status: fact or fiction? British Journal of Cancer, 111(8), 1678-1679. [More Information]
  • Menzies, A., Lum, T., Wilmott, J., Hyman, J., Kefford, R., Thompson, J., O'Toole, S., Long, G., Scolyer, R. (2014). Intrapatient Homogeneity of BRAFV600E Expression in Melanoma. The American Journal of Surgical Pathology, 38(3), 377-382. [More Information]
  • Larson, A., Dresser, K., Zhan, Q., Lezcano, C., Woda, B., Yosufi, B., Thompson, J., Scolyer, R., Mihm, M., Shi, Y., et al (2014). Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Modern Pathology, 27(7), 936-944. [More Information]
  • van der Ploeg, A., Haydu, L., Spillane, A., Scolyer, R., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2014). Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease. Annals of Surgical Oncology, 21(9), 3108-3116. [More Information]
  • Becker, T., Boyd, S., Mijatov, B., Gowrishankar, K., Snoyman, S., Pupo, G., Scolyer, R., Mann, G., Kefford, R., Zhang, X., Rizos, H. (2014). Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor. Oncogene, 33(9), 1158-1166. [More Information]
  • Liu, Y., Lai, F., Wilmott, J., Yan, X., Liu, X., Luan, Q., Guo, S., Jiang, C., Tseng, H., Scolyer, R., et al (2014). Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells. Oncotarget, 5(22), 11237-11251.
  • Dong, L., Jin, L., Tseng, H., Wang, C., Wilmott, J., Yosufi, B., Yan, X., Jiang, C., Jiang, C., Scolyer, R., et al (2014). Oncogenic suppression of PHLPP1 in human melanoma. Oncogene, 33(39), 4756-4766. [More Information]
  • van der Ploeg, A., Haydu, L., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R., Scolyer, R., Thompson, J. (2014). Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution. Annals of Surgery, 260(1), 149-157. [More Information]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2014). Pathology Review Significantly Affects Diagnosis and Treatment of Melanoma Patients: An Analysis of 5011 Patients Treated at a Melanoma Treatment Center. Annals of Surgical Oncology, 21(7), 2245-2251. [More Information]
  • Carlino, M., Fung, C., Shahheydari, H., Todd, J., Boyd, S., Irvine, M., Nagrial, A., Scolyer, R., Kefford, R., Long, G., Rizos, H. (2014). Pre-existing MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients. Clinical Cancer Research, 21(1), 98-105. [More Information]
  • Song, E., Scolyer, R., Damian, D., Thompson, J. (2014). Primary oesophageal melanoma - a case report. World Journal of Surgical Oncology, 12(1), 77-77. [More Information]
  • Mactier, S., Kaufman (nee Alexander), K., Wang, P., Crossett, B., Pupo, G., Kohnke, P., Thompson, J., Scolyer, R., Yang, J., Mann, G., Christopherson, R. (2014). Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients. Pigment Cell & Melanoma Research, 27(6), 1106-1116. [More Information]
  • Fogarty, G., Hong, A., Scolyer, R., Lin, E., Haydu, L., Guitera, P., Thompson, J. (2014). Radiotherapy for lentigo maligna - a literature review and recommendations for treatment. British Journal of Dermatology, 170(1), 52-58. [More Information]
  • Zimmer, L., Haydu, L., Menzies, A., Scolyer, R., Kefford, R., Thompson, J., Schadendorf, D., Long, G. (2014). Reply to M. Perier-Muzet et al. Journal of Clinical Oncology, 32(28), 3203-3204. [More Information]
  • Parmenter, T., Kleinschmidt, M., Kinross, K., Bond, S., Li, J., Kaadige, M., Rao, A., Sheppard, K., Hugo, W., Pupo, G., Long, G., Scolyer, R., Rizos, H., et al (2014). Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discovery, 4(4), 423-433. [More Information]
  • Kaufman (nee Alexander), K., Mactier, S., Armstrong, N., Mallawaaratchy, D., Byrne, S., Haydu, L., Jakrot, V., Thompson, J., Mann, G., Scolyer, R., Christopherson, R. (2014). Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients. Clinical and Experimental Metastasis, 31, 407-421. [More Information]
  • Guitera, P., Haydu, L., Menzies, S., Scolyer, R., Hong, A., Fogarty, G., Gallardo, F., Segura, S. (2014). Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors. British Journal of Dermatology, 170(6), 1305-1312. [More Information]
  • Chien, A., Haydu, L., Biechele, T., Kulikauskas, R., Rizos, H., Kefford, R., Scolyer, R., Moon, R., Long, G. (2014). Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/Beta-Catenin Signaling. PloS One, 9(4), 1-11.
  • Lamboo, L., Haydu, L., Scolyer, R., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Bonenkamp, J., Thompson, J. (2014). The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in thickness): A retrospective study of 1587 patients treated at a single center. Annals of Surgery, 260(6), 1095-1102. [More Information]
  • van der Ploeg, A., Akkooi, A., Haydu, L., Scolyer, R., Murali, R., Verhoef, C., Thompson, J., Eggermont, A. (2014). The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. European Journal of Cancer, 50(1), 111-120. [More Information]
  • Sutton, S., Koach, J., Tan, O., Liu, B., Carter, D., Wilmott, J., Yosufi, B., Haydu, L., Mann, G., Thompson, J., Long, G., Scolyer, R., et al (2014). TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells. Oncotarget, 5(20), 10127-10139.
  • Schatton, T., Scolyer, R., Thompson, J., Mihm Jnr, M. (2014). Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. In Magdalena Thurim, Francesco M. Marincola (Eds.), Molecular Diagnostics for Melanoma: Methods and Protocols, (pp. 287-324). New York: Humana Press. [More Information]

2013

  • Hu, W., Jin, L., Jiang, C., Long, G., Scolyer, R., Wu, Q., Zhang, X., Mei, Y., Wu, M. (2013). AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma. Cell Death and Disease, 4(11), 1-11. [More Information]
  • Wevers, K., Murali, R., Bastiaannet, E., Scolyer, R., Suurmeijer, A., Thompson, J., Hoekstra, H. (2013). Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients. European Journal of Surgical Oncology, 39(2), 179-184. [More Information]
  • Bogun, Y., Scolyer, R., Guitera, P. (2013). Asymptomatic linear pigmentation of the skin. International Journal Of Dermatology, 52(8), 935-937. [More Information]
  • Murali, R., Wilmott, J., Jakrot, V., Al-Ahmadie, H., Wiesner, T., McCarthy, S., Thompson, J., Scolyer, R. (2013). BAP1 expression in cutaneous melanoma: a pilot study. Pathology, 45(6), 606-609. [More Information]
  • Scolyer, R., Thompson, J. (2013). Biospecimen banking: The pathway to personalized medicine for patients with cancer. Journal of Surgical Oncology, 107(7), 681-682. [More Information]
  • Mann, G., Pupo, G., Campain, A., Carter, C., Schramm, S., Pianova, S., Gerega, S., Desilva, C., Lai, K., Wilmott, J., Hersey, P., Kefford, R., Thompson, J., Yang, J., Scolyer, R., et al (2013). BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma. Journal of Investigative Dermatology, 133(2), 509-517. [More Information]
  • Wilmott, J., Menzies, A., Haydu, L., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Diemling, A., Scolyer, R., Long, G. (2013). BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma. British Journal of Cancer, 108(4), 924-931. [More Information]
  • Mar, V., Wong, S., Li, J., Scolyer, R., McLean, C., Papenfuss, A., Tothill, R., Kakavand, H., Mann, G., Thompson, J., et al (2013). BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage. Clinical Cancer Research, 19(17), 4589-4598. [More Information]
  • Murali, R., Scolyer, R., Thompson, J. (2013). Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes. European Journal of Surgical Oncology, 39(10), 1164-1165. [More Information]
  • Shiau, C., Thompson, J., Scolyer, R. (2013). Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna. Expert Review of Dermatology, 8(2), 195-214. [More Information]
  • Scolyer, R., Judge, M., Evans, A., Frishberg, D., Prieto, V., Thompson, J., Trotter, M., Walsh, M., Walsh, N., Ellis, D. (2013). Data set for pathology reporting of cutaneous invasive melanoma: Recommendations from the international collaboration on cancer reporting (ICCR). The American Journal of Surgical Pathology, 37(12), 1797-1814. [More Information]
  • Menzies, S., Moloney, F., Byth Wilson, K., Avramidis, M., Argenziano, G., Zalaudek, I., Braun, R., Malvehy, J., Puig, S., Rabinovitz, H., Scolyer, R., Guitera, P., Coates, E., et al (2013). Dermoscopic evaluation of nodular melanoma. JAMA Dermatology, 149(6), 699-709. [More Information]
  • Scolyer, R., Karim, R., Thompson, J., Stretch, J., McCarthy, S., Murali, R. (2013). Digital papillary adenocarcinoma: a tumour that should be considered in the differential diagnosis of neoplasms involving the digits. Pathology, 45(1), 55-61. [More Information]
  • Schramm, S., Li, S., Jayaswal, V., Fung, D., Campain, A., Pang, C., Scolyer, R., Yang, J., Mann, G., Wilkins, M. (2013). Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden. Pigment Cell & Melanoma Research, 26(5), 708-722. [More Information]
  • Long, G., Wilmott, J., Haydu, L., Tembe, V., Sharma, R., Rizos, H., Thompson, J., Howle, J., Scolyer, R., Kefford, R. (2013). Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment and on progression. Pigment Cell & Melanoma Research, 26(4), 499-508. [More Information]
  • Kakavand, H., Scolyer, R., Thompson, J., Mann, G. (2013). Identification of new prognostic biomarkers for Stage III metastatic melanoma patients. OncoImmunology, 2(9), e25564-1-e25564-3. [More Information]
  • Long, G., Wilmott, J., Capper, D., Preusser, M., Zhang, Y., Thompson, J., Kefford, R., von Deimling, A., Scolyer, R. (2013). Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma. The American Journal of Surgical Pathology, 37(1), 61-65. [More Information]
  • Guitera, P., Moloney, F., Menzies, S., Stretch, J., Quinn, M., Hong, A., Fogarty, G., Scolyer, R. (2013). Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy. JAMA Dermatology, 149(6), 692-698. [More Information]
  • Ryu, S., Robyn, S., Scolyer, R., Crawford, M., Thompson, J., Sandroussi, C. (2013). Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries. Journal of Surgical Oncology, 108(2), 129-135. [More Information]
  • Pasquali, S., van der Ploeg, A., Mocellin, S., Stretch, J., Thompson, J., Scolyer, R. (2013). Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell & Melanoma Research, 26(3), 326-337. [More Information]
  • Harish, V., Bond, J., Scolyer, R., Haydu, L., Saw, R., Quinn, M., Benger, R., Uren, R., Stretch, J., Shannon, K., Thompson, J. (2013). Margins of excision and prognostic factors for cutaneous eyelid melanomas. Journal of Plastic, Reconstructive and Aesthetic Surgery, 66(8), 1066-1073. [More Information]
  • Dutton-Regester, K., Kakavand, H., Aoude, L., Stark, M., Gartside, M., Johansson, P., O'Connor, L., Lanagan, C., Tembe, V., Pupo, G., Haydu, L., Mann, G., Thompson, J., Scolyer, R., et al (2013). Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma. Pigment Cell & Melanoma Research, 26(6), 852-860. [More Information]
  • Scolyer, R., Thompson, J. (2013). Mitotic rate in melanoma should be recorded as the number of mitoses per mm(2) (not per high power field): surgeons tell your pathologists!. The American Journal Of Surgery, 206(1), 142-143. [More Information]
  • Murali, R., Scolyer, R., Armstrong, B. (2013). Multiple primary cutaneous melanomas: recent studies highlight features associated with more indolent behaviour. Pathology, 45(1), 1-3. [More Information]
  • Boyd, S., Mijatov, B., Pupo, G., Tran, S., Gowrishankar, K., Shaw, H., Goding, C., Scolyer, R., Mann, G., Kefford, R., Rizos, H., Becker, T. (2013). Oncogenic B-RAF(V600E) Signaling Induces the T-Box3 Transcriptional Repressor to Repress E-Cadherin and Enhance Melanoma Cell Invasion. Journal of Investigative Dermatology, 133(5), 1269-1277. [More Information]
  • Gerami, P., Cooper, C., Bajaj, S., Wagner, A., Fullen, D., Busam, K., Scolyer, R., Xu, X., Elder, D., Abraham, R., et al (2013). Outcomes of atypical spitz tumors with chromosomal copy number aberrations and conventional melanomas in children. American Journal of Surgical Pathology, 37(9), 1387-1394. [More Information]
  • Fung, C., Pupo, G., Scolyer, R., Kefford, R., Rizos, H. (2013). p16INK4a deficiency promotes DNA hyper-replication and genetic instability in melanocytes. Pigment Cell & Melanoma Research, 26(2), 236-246. [More Information]
  • Sarchio, S., Scolyer, R., Beaugie, C., McDonald, D., Marsh-Wakefield, F., Halliday, G., Byrne, S. (2013). Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer. Journal of Investigative Dermatology, 134(4), 1091-1100. [More Information]
  • Ye, Y., Jin, L., Wilmott, J., Hu, W., Yosufi, B., Thorne, R., Liu, T., Rizos, H., Yan, X., Dong, L., Hersey, P., Scolyer, R., et al (2013). PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma. Nature Communications, 4, 1-15. [More Information]
  • Delahunt, B., Scolyer, R., Srigley, J. (2013). Premalignancy: The lull before the storm. Pathology, 45(3), 207-208. [More Information]
  • Karim, R., O'Toole, S., Scolyer, R., Cooper, C., Chan, B., Selinger, C., Yu, B., Carmalt, H., Mak, C., Tse, G., Lee, C., et al (2013). Recent insights into the molecular pathogenesis of mammary phyllodes tumours. Journal of Clinical Pathology, 66(6), 496-505. [More Information]
  • Guitera, P., Scolyer, R., Gill, M., Akita, H., Arima, M., Yokoyama, Y., Matsunaga, K., Longo, C., Bassoli, S., Bencini, P., et al (2013). Reflectance confocal microscopy for diagnosis of mammary and extramammary Paget's disease. European Academy of Dermatology and Venereology. Journal, 27(1), e24-e29. [More Information]
  • Niebling, M., Haydu, L., Karim, R., Thompson, J., Scolyer, R. (2013). Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases. Annals of Surgical Oncology, 20(12), 3969-3975. [More Information]
  • Gerami, P., Scolyer, R., Xu, X., Elder, D., Abraham, R., Fullen, D., Prieto, V., LeBoit, P., Barnhill, R., Cooper, C., et al (2013). Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. American Journal of Surgical Pathology, 37(5), 676-684. [More Information]
  • Cho, E., Moloney, F., Cai, H., Au-Yeung, A., China, C., Scolyer, R., Yosu�?, B., Raftery, M., Deng, J., Morton, S., Damian, D., Barnetson, R., Halliday, G., et al (2013). Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). The Lancet, 381(9880), 1835-1843. [More Information]
  • Pasquali, S., Haydu, L., Scolyer, R., Winstanley, J., Spillane, A., Quinn, M., Saw, R., Shannon, K., Stretch, J., Thompson, J. (2013). The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas. Annals of Surgery, 258(1), 152-157. [More Information]
  • Hruby, G., Scolyer, R., Thompson, J. (2013). The important role of radiation treatment in the management of Merkel cell carcinoma. British Journal of Dermatology, 169(5), 975-982. [More Information]
  • Murali, R., Wiesner, T., Scolyer, R. (2013). Tumours associated with BAP1 mutations. Pathology, 45(2), 116-126. [More Information]

2012

  • Dutton-Regester, K., Irwin, D., Hunt, P., Aoude, L., Tembe, V., Pupo, G., Lanagan, C., Carter, C., O'Connor, L., O'Rourke, M., Scolyer, R., Mann, G., et al (2012). A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma. Molecular Cancer Therapeutics, 11(4), 888-897. [More Information]
  • Huynh, K., Takei, Y., Scolyer, R., Murali, R., Chong, K., Takeshima, L., Sim, M., Morton, D., Turner, R., Thompson, J., et al (2012). Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma. British Journal of Dermatology, 166(6), 1319-1326. [More Information]
  • Tran, S., Haferkamp, S., Scurr, L., Gowrishankar, K., Becker, T., Desilva, C., Thompson, J., Scolyer, R., Kefford, R., Rizos, H. (2012). Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi. Journal of Investigative Dermatology, 132(9), 2226-2234. [More Information]
  • Burmeister, B., Henderson, M., Ainslie, J., Fisher, R., Dilulio, J., Smithers, B., Hong, A., Shannon, K., Scolyer, R., Carruthers, S., Thompson, J., et al (2012). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. The Lancet Oncology, 13(6), 589-597. [More Information]
  • Wilmott, J., Haydu, L., Bagot, M., Zhang, Y., Jakrot, V., McCarthy, S., Lugassy, C., Thompson, J., Scolyer, R., Jakrot, V., et al (2012). Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma. Histopathology, 61(5), 889-898. [More Information]
  • Murali, R., Scolyer, R., Thompson, J. (2012). Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death? Annals of Surgical Oncology, 19(11), 3310-3312. [More Information]
  • Murali, R., Haydu, L., Long, G., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Kefford, R., Thompson, J., Scolyer, R. (2012). Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma. Annals of Surgical Oncology, 19(6), 1782-1789. [More Information]
  • Murali, R., Goumas, C., Kricker, A., From, L., Busam, K., Begg, C., Dwyer, T., Gruber, S., Kanetsky, P., Orlow, I., Scolyer, R., Armstrong, B., et al (2012). Clinicopathologic Features of Incident and Subsequent Tumors in Patients with Multiple Primary Cutaneous Melanomas. Annals of Surgical Oncology, 19(3), 1024-1033. [More Information]
  • Wilmott, J., Scolyer, R., Long, G., Hersey, P. (2012). Combined targeted therapy and immunotherapy in the treatment of advanced melanoma. OncoImmunology, 1(6), 997-999. [More Information]
  • Anforth, R., Blumetti, T., Kefford, R., Sharma, R., Scolyer, R., Kossard, S., Long, G., Fernandez Penas, P. (2012). Cutaneous Manifestations of Dabrafenib (GSK2118436): A Selective Inhibitor of Mutant BRAF in patients with Metastatic Melanoma. British Journal of Dermatology, 167(5), 1153-1160. [More Information]
  • Koh, S., Wei, J., Li, X., Huang, R., Doan, N., Scolyer, R., Cochran, A., Binder, S. (2012). Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases. Modern Pathology, 25(6), 828-837. [More Information]
  • Menzies, A., Haydu, L., Visintin, L., Carlino, M., Howle, J., Thompson, J., Kefford, R., Scolyer, R., Long, G. (2012). Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma. Clinical Cancer Research, 18(12), 3242-3249. [More Information]
  • Tsang, J., Mendoza, P., Putti, T., Karim, R., Scolyer, R., Lee, C., Pang, A., Tse, G. (2012). E-cadherin expression in the epithelial components of mammary phyllodes tumors. Human Pathology, 43(12), 2117-2123. [More Information]
  • Salim, A., Karim, R., McCarthy, S., Scolyer, R. (2012). Endocrine mucin producing sweat gland carcinoma: a clinicopathological analysis of three cases. Pathology, 44(6), 568-571. [More Information]
  • Huang, X., Scolyer, R., Abubakar, A., Halliday, G. (2012). Human 8-oxoguanine-DNA glycosylase-1 is downregulated in human basal cell carcinoma. Molecular Genetics and Metabolism, 106(1), 127-130. [More Information]
  • Dutton-Regester, K., Aoude, L., Nancarrow, D., Stark, M., O'Connor, L., Lanagan, C., Pupo, G., Tembe, V., Carter, C., O'Rourke, M., Scolyer, R., Mann, G., et al (2012). Identification of TFG (TRK-Fused Gene) as a Putative Metastatic Melanoma Tumor Suppressor Gene. Genes Chromosomes and Cancer, 51(5), 452-461. [More Information]
  • Guitera, P., Menzies, S., Longo, C., Cesinaro, A., Scolyer, R., Pellacani, G. (2012). In Vivo Confocal Microscopy for Diagnosis of Melanoma and Basal Cell Carcinoma Using a Two-Step Method: Analysis of 710 Consecutive Clinically Equivocal Cases. Journal of Investigative Dermatology, 132(10), 2386-2394. [More Information]
  • Lim, C., Whalley, D., Haydu, L., Murali, R., Tippett, J., Thompson, J., Hruby, G., Scolyer, R. (2012). Increasing Tumor Thickness is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma. Annals of Surgical Oncology, 19(11), 3325-3334. [More Information]
  • Wilmott, J., Tembe, V., Howle, J., Sharma, R., Thompson, J., Rizos, H., Lo, R., Kefford, R., Scolyer, R., Long, G. (2012). Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine. Molecular Cancer Therapeutics, 11(12), 2704-2708. [More Information]
  • Tsang, J., Mendoza, P., Lam, C., Yui, A., Putti, T., Karim, R., Scolyer, R., Lee, C., Tan, P., Tse, G. (2012). Involvement of a- and B-catenins and E-cadherin in the development of mammary phyllodes tumours. Histopathology, 61(4), 667-674. [More Information]
  • Lian, C., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., Scolyer, R., Thompson, J., Kakavand, H., et al (2012). Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma. Cell, 150(6), 1135-1146. [More Information]
  • Shayan, R., Karnezis, T., Murali, R., Wilmott, J., Ashton, M., Taylor, G., Thompson, J., Hersey, P., Achen, M., Scolyer, R., et al (2012). Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis. Histopathology, 61(4), 702-710. [More Information]
  • Shi, H., Moriceau, G., Kong, X., Lee, M., Lee, H., Koya, R., Ng, C., Chodon, T., Scolyer, R., Dahlman, K., Kefford, R., Long, G., et al (2012). Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance. Nature Communications, 3(20122), 1-8. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2012). Melanoma: A management guide for GPs. Australian Family Physician, 41(7), 470-473. [More Information]
  • Murali, R., Brown, P., Kefford, R., Scolyer, R., Thompson, J., Atkins, M., Long, G. (2012). Number of Primary Melanomas Is an Independent Predictor of Survival in Patients With Metastatic Melanoma. Cancer, 118(18), 4519-4529. [More Information]
  • Lim, C., Thompson, J., McKenzie, P., McCarthy, S., Scolyer, R. (2012). Peritoneal melanosis associated with metastatic melanoma involving the omentum. Pathology, 44(3), 255-257. [More Information]
  • in 't Hout, F., Haydu, L., Murali, R., Bonenkamp, J., Thompson, J., Scolyer, R. (2012). Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma. Annals of Surgery, 255(6), 1165-1170. [More Information]
  • Schramm, S., Campain, A., Scolyer, R., Yang, J., Mann, G. (2012). Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis. Journal of Investigative Dermatology, 132(2), 274-283. [More Information]
  • Wilmott, J., Long, G., Howle, J., Haydu, L., Sharma, R., Thompson, J., Kefford, R., Hersey, P., Scolyer, R. (2012). Selective BRAF inhibitors induce marked T - cell infiltration into human metastatic melanoma. Clinical Cancer Research, 18(5), 1386-1394. [More Information]
  • Scurr, L., McKenzie, H., Becker, T., Irvine, M., Lai, K., Mann, G., Scolyer, R., Kefford, R., Rizos, H. (2012). Selective Loss of Wild-Type p16(INK4a) Expression in Human Nevi. Journal of Investigative Dermatology, 131(11), 2329-2332. [More Information]
  • Murali, R., Haydu, L., Quinn, M., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma. Annals of Surgery, 255(1), 128-133. [More Information]
  • Murali, R., Desilva, C., McCarthy, S., Thompson, J., Scolyer, R. (2012). Sentinel Lymph Nodes Containing Very Small (<0.1 mm) Deposits of Metastatic Melanoma Cannot Be Safely Regarded as Tumor-Negative. Annals of Surgical Oncology, 19(4), 1089-1099. [More Information]
  • Girouard, S., Laga, A., Mihm, M., Scolyer, R., Thompson, J., Zhan, Q., Widlund, H., Lee, C., Murphy, G. (2012). SOX2 contributes to melanoma cell invasion. Laboratory Investigation, 92(3), 362-370. [More Information]
  • Chua, T., Scolyer, R., Kennedy, C., Yan, T., McCaughan, B., Thompson, J. (2012). Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients. Annals of Surgical Oncology, 19(6), 1774-1781. [More Information]
  • Halliday, G., Zhou, Y., Sou, P., Huang, X., Rana, S., Bugeja, M., Painter, N., Scolyer, R., Muchardt, C., Di Girolamo, N., Lyons, G. (2012). The absence of Brm exacerbates photocarcinogenesis. Experimental Dermatology, 21(8), 599-604. [More Information]
  • Cheung, B., Koach, J., Tan, O., Kim, P., Bell, J., D'andreti, C., Sutton, S., Malyukova, A., Sekyere, E., Norris, M., Wilmott, J., Cooper, C., Halliday, G., Scolyer, R., et al (2012). The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro. Journal of Pathology, 226(3), 451-462. [More Information]
  • Azimi, F., Scolyer, R., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S., Saw, R., Thompson, J. (2012). Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma. Journal of Clinical Oncology, 30(21), 2678-2683. [More Information]

2011

  • Bauer, J., Buttner, P., Murali, R., Okamoto, I., Kolaitis, N., Landi, M., Scolyer, R., Bastian, B. (2011). BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell & Melanoma Research, 24(2), 345-351. [More Information]
  • Bock, V., Lyons, G., Huang, X., Jones, A., McDonald, L., Scolyer, R., Moloney, F., Barnetson, R., Halliday, G. (2011). BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. British Journal of Dermatology, 164(6), 1221-1227. [More Information]
  • Svobodova, S., Browning, J., MacGregor, D., Pollara, G., Scolyer, R., Murali, R., Thompson, J., Deb, S., Azad, A., Davis, I., et al (2011). Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. European Journal of Cancer, 47(3), 460-469. [More Information]
  • Murali, R., Zannino, D., Synnott, M., McCarthy, S., Thompson, J., Scolyer, R. (2011). Clinical and Pathological Features of Metastases of Primary Cutaneous Desmoplastic Melanoma. Histopathology, 58(6), 886-895. [More Information]
  • Scolyer, R., Long, G., Thompson, J. (2011). Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Molecular Oncology, 5(2), 124-136. [More Information]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2011). Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients. Annals of Surgery, 253(6), 1155-1164. [More Information]
  • Hollingsworth, J., Cooper, W., Nicoll, K., Wills, E., Thiruvilangam, V., Lee, C., Scolyer, R. (2011). Follicular dendritic cell sarcoma of the lung: a report of two cases highlighting its pathological features and diagnostic pitfalls. Pathology, 43(1), 67-70. [More Information]
  • Hersey, P., Smalley, K., Weeraratna, A., Bosenberg, M., Zhang, X., Haass, N., Paton, E., Mann, G., Scolyer, R. (2011). Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010. Pigment Cell & Melanoma Research, 24(1), e1-e15. [More Information]
  • Scolyer, R., Prieto, V. (2011). Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients. Surgical Oncology Clinics of North America, 20(1), 19-37. [More Information]
  • Schrama, D., Peitsch, W., Zapatka, M., Kneitz, H., Houben, R., Eib, S., Haferkamp, S., Moore, P., Shuda, M., Thompson, J., Scolyer, R., et al (2011). Merkel Cell Polyomavirus Status Is Not Associated with Clinical Course of Merkel Cell Carcinoma. Journal of Investigative Dermatology, 131(8), 1631-1638. [More Information]
  • Jin, L., Hu, W., Jiang, C., Wang, J., Han, C., Chu, P., Zhang, L., Thorne, R., Wilmott, J., Scolyer, R., Hersey, P., et al (2011). MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proceedings of the National Academy of Sciences of the United States of America, 108(38), 15840-15845. [More Information]
  • Zembowicz, A., Scolyer, R. (2011). Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms? Archives of Pathology & Laboratory Medicine, 135(34), 300-306. [More Information]
  • Long, G., Menzies, A., Nagrial, A., Haydu, L., Hamilton, A., Mann, G., Hughes, T., Thompson, J., Scolyer, R., Kefford, R. (2011). Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma. Journal of Clinical Oncology, 29(10), 1239-1246. [More Information]
  • Nielsen, K., Chakera, A., Hesse, B., Scolyer, R., Stretch, J., Thompson, J., Nielsen, M., Uren, R., Oturai, P. (2011). The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. European Journal of Nuclear Medicine and Molecular Imaging, 38(11), 1999-2004. [More Information]
  • Wilmott, J., Zhang, X., Hersey, P., Scolyer, R. (2011). The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology, 43(6), 657-671. [More Information]
  • Verwer, N., Scolyer, R., Uren, R., Winstanley, J., Brown, P., de Wilt, J., Thompson, J. (2011). Treatment and Prognostic Significance of Positive Interval Sentinel Nodes in Patients with Primary Cutaneous Melanoma. Annals of Surgical Oncology, 18(12), 3292-3299. [More Information]

2010

  • Kaufman (nee Alexander), K., Belov, L., Huang, P., Mactier, S., Scolyer, R., Mann, G., Christopherson, R. (2010). An extended antibody microarray for surface profiling metastatic melanoma. Journal of Immunological Methods, 358(40210 (1-2)), 23-34. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2010). Can Histologic Parameters of Melanoma Metastases in Sentinel Lymph Nodes Reliably Select Patients Who Can Be Safely Spared Completion Lymph Node Dissection? Annals of Surgery, 251(6), 1188-9; author reply 1189-90. [More Information]
  • Guitera, P., Bourgeat, P., Stretch, J., Scolyer, R., Ourselin, S., Lean, C., Thompson, J., Bourne, R. (2010). Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies. Melanoma Research, 20(4), 311-317. [More Information]
  • Murali, R., Thompson, J., Uren, R., Scolyer, R. (2010). Fine-needle biopsy of metastatic melanoma: clinical use and new applications. Lancet Oncology, 11(4), 391-400. [More Information]
  • Broekaert, S., Roy, R., Okamoto, I., van den Oord, J., Bauer, J., Garbe, C., Barnhill, R., Busam, K., Cochran, A., Cook, M., McCarthy, S., Scolyer, R., et al (2010). Genetic and morphologic features for melanoma classification. Pigment Cell & Melanoma Research, 23(6), 763-770. [More Information]
  • Goto, Y., Arigami, T., Murali, R., Scolyer, R., Tanemura, A., Takata, M., Turner, R., Nguyen, L., Nguyen, T., Morton, D., et al (2010). High Molecular Weight-Melanoma-Associated Antigen as a Biomarker of Desmoplastic Melanoma. Pigment Cell & Melanoma Research, 23(1), 137-40. [More Information]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2010). Histologically Ambiguous ("Borderline") Primary Cutaneous Melanocytic Tumors - Approaches to Patient Management Including the Roles of Molecular Testing and Sentinel Lymph Node Biopsy. Archives of Pathology and Laboratory Medicine, 134(12), 1770-1777. [More Information]
  • Scurr, L., Pupo, G., Becker, T., Lai, K., Schrama, D., Haferkamp, S., Irvine, M., Scolyer, R., Mann, G., Becker, J., Kefford, R., Rizos, H. (2010). IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence. Cell, 141(4), 717-727. [More Information]
  • Zhuang, L., Scolyer, R., Murali, R., McCarthy, S., Zhang, X., Thompson, J., Hersey, P. (2010). Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins. Modern Pathology, 23(1), 45-53. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2010). Location of Melanoma Metastases in Sentinel Lymph Nodes: What are the Implications for Histologic Processing of Sentinel Lymph Nodes in Routine Practice? The American Journal of Surgical Pathology, 34(1), 127-129. [More Information]
  • Verwer, N., Murali, R., Winstanley, J., Cooper, W., Stretch, J., Thompson, J., Scolyer, R. (2010). Lymphoma occurring in patients with cutaneous melanoma. Journal of Clinical Pathology, 63(9), 777-781. [More Information]
  • Field, A., McKenzie, P., McLeod, D., Stretch, J., Thompson, J., Scolyer, R. (2010). Melanotic schwannoma mimicking metastatic pigmented melanoma: a pitfall in cytological diagnosis. Pathology, 42(3), 287-289. [More Information]
  • Guitera, P., Li, L., Scolyer, R., Menzies, S. (2010). Morphologic Features of Melanophages Under In Vivo Reflectance Confocal Microscopy. Archives of Dermatology, 146(5), 492-498. [More Information]
  • Murali, R., Desilva, C., Thompson, J., Scolyer, R. (2010). Non-Sentinel Node Risk Score (N-SNORE): A Scoring System for Accurately Stratifying Risk of Non-Sentinel Node Positivity in Patients With Cutaneous Melanoma With Positive Sentinel Lymph Nodes. Journal of Clinical Oncology, 28(29), 4441-4449. [More Information]
  • Karim, R., Gerega, S., Yang, J., Spillane, A., Carmalt, H., Scolyer, R., Lee, C. (2010). p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours. Histopathology, 56(7), 868-875. [More Information]
  • McCarthy, S., Scolyer, R. (2010). Pitfalls and Important Issues in the Pathologic Diagnosis of Melanocytic Tumors. The Ochsner Journal, 10, 66-74.
  • Murali, R., Shaw, H., McCarthy, S., Quinn, M., Stretch, J., Thompson, J., Scolyer, R. (2010). Prognostic Factors in Cutaneous Desmoplastic Melanoma: A Study of 252 Patients. Cancer, 116(17), 4130-4138. [More Information]
  • Haydu, L., Holt, P., Karim, R., Madronio, C., Thompson, J., Armstrong, B., Scolyer, R. (2010). Quality of histopathological reporting on melanoma and influence of use of a synoptic template. Histopathology, 56(6), 768-774. [More Information]
  • Cadili, A., Dabbs, K., Scolyer, R., Brown, P., Thompson, J. (2010). Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients. Journal of the American College of Surgeons, 211(4), 522-525. [More Information]
  • Lim, C., Cooper, C., Delprado, W., McCarthy, S., Scolyer, R. (2010). Retroperitoneal inflammatory liposarcoma in a patient with non-hodgkin lymphoma: a report highlighting diagnostic pitfalls. Pathology Research International, 2010, 505436. [More Information]
  • Wiener, M., Acland, K., Shaw, H., Soong, S., Li, H., Chen, D., Scolyer, R., Winstanley, J., Thompson, J. (2010). Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model. Annals of Surgical Oncology, 17(8), 1995-2005. [More Information]
  • Barnhill, R., Cerroni, L., Cook, M., Elder, D., Kerl, H., LeBoit, P., McCarthy, S., Mihm, M., Mooi, W., Piepkorn, M., Scolyer, R., et al (2010). State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Advances in Anatomic Pathology, 17(2), 73-90. [More Information]
  • Cooper, C., Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Thompson, J., Scolyer, R. (2010). Synchronous and metachronous malignancies in patients with melanoma: a clinicopathologic study highlighting the role of fine-needle biopsy cytology and potential diagnostic pitfalls. Melanoma Research, 20(3), 203-211. [More Information]
  • Mocellin, S., Shrager, J., Scolyer, R., Pasquali, S., Verdi, D., Marincola, F., Briarava, M., Gobbel, R., Rossi, C., Nitti, D. (2010). Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology. PloS One, 5(8), e11965-1-e11965-11. [More Information]
  • Martiniuk, F., Damian, D., Thompson, J., Scolyer, R., Tchou-Wong, K., Levis, W. (2010). TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. Journal of Drugs in Dermatology: new methods and technology, 9(11), 1368-1372. [More Information]
  • Guitera, P., Pellacani, G., Crotty, K., Scolyer, R., Li, L., Bassoli, S., Vinceti, M., Rabinovitz, H., Longo, C., Menzies, S. (2010). The Impact of In Vivo Reflectance Confocal Microscopy on the Diagnostic Accuracy of Lentigo Maligna and Equivocal Pigmented and Nonpigmented Macules of the Face. Journal of Investigative Dermatology, 130(8), 2080-2091. [More Information]
  • Murali, R., Moncrieff, M., Hong, J., Cooper, C., Shingde, M., Samuel, D., Thompson, J., Scolyer, R. (2010). The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma. Annals of Surgical Oncology, 17(11), 2992-2999. [More Information]
  • Cadili, A., Scolyer, R., Brown, P., Dabbs, K., Thompson, J. (2010). Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma. Annals of Surgical Oncology, 17(11), 3015-3020. [More Information]
  • Murali, R., Scolyer, R. (2010). Tumor-infiltrating lymphocytes and mitotic index in metastatic melanoma as predictors of patient survival. Proceedings of the National Academy of Sciences of the United States of America, 107(13), E46; author reply E47. [More Information]

2009

  • Busam, K., Murali, R., Pulitzer, M., McCarthy, S., Thompson, J., Shaw, H., Brady, M., Coit, D., Dusza, S., Wilmott, J., Scolyer, R., et al (2009). Atypical Spitzoid Melanocytic Tumors With Positive Sentinel Lymph Nodes in Children and Teenagers, and Comparison With Histologically Unambiguous and Lethal Melanomas. American Journal of Surgical Pathology, 33(9), 1386-1395. [More Information]
  • Murali, R., McCarthy, S., Scolyer, R. (2009). Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Advances in Anatomic Pathology, 16(6), 365-382. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2009). Cutaneous melanoma in the era of molecular profiling. The Lancet, 374(9687), 362-365. [More Information]
  • Cooper, C., Danieletto, S., Fong, E., Harris, M., Konya, J., Cooper, W., McCarthy, S., Scolyer, R. (2009). Cutaneous metastasis of epithelioid haemangioendothelioma. Pathology, 41(6), 585-587. [More Information]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2009). Cytological features of melanoma in exfoliative fluid specimens. Journal of Clinical Pathology, 62(7), 638-643. [More Information]
  • Morey, A., Murali, R., McCarthy, S., Mann, G., Scolyer, R. (2009). Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology, 41(4), 383-387. [More Information]
  • Chakera, A., Hesse, B., Burak, Z., Ballinger, J., Britten, A., Caraco, C., Cochran, A., Cook, M., Drzewiecki, K., Scolyer, R., Thompson, J., Uren, R., et al (2009). EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. European Journal of Nuclear Medicine and Molecular Imaging, 36(10), 1713-1742. [More Information]
  • Hare, D., Burger, F., Austin, C., Fryer, F., Grimm, R., Reedy, B., Scolyer, R., Thompson, J., Doble, P. (2009). Elemental bio-imaging of melanoma in lymph node biopsies. The Analyst, 134(3), 450-453. [More Information]
  • Orlow, I., Tommasi, D., Bloom, B., Ostrovnaya, I., Cotignola, J., Mujumdar, U., Busam, K., Jungbluth, A., Scolyer, R., Thompson, J., Armstrong, B., et al (2009). Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling. Journal of Investigative Dermatology, 129(8), 1972-1982. [More Information]
  • Zhuang, L., Scolyer, R., Lee, C., McCarthy, S., Cooper, W., Zhang, X., Thompson, J., Hersey, P. (2009). Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology, 54(4), 462-470. [More Information]
  • Lam, T., Uren, R., Scolyer, R., Shannon, K., Thompson, J. (2009). False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Research, 19(2), 94-99. [More Information]
  • Narita, N., Tanemura, A., Murali, R., Scolyer, R., Huang, S., Arigami, T., Yanagita, S., Chong, K., Thompson, J., Morton, D., et al (2009). Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene, 28(34), 3058-3068. [More Information]
  • Tse, G., Lui, P., Vong, J., Yu, A., Putti,, T., Karim, R., Scolyer, R., Lee, C., Ng, D., Tse, A., et al (2009). Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Research and Treatment, 114(3), 441-448. [More Information]
  • Murali, R., Cochran, A., Cook, M., Hillman, J., Karim, R., Moncrieff, M., Starz, H., Thompson, J., Scolyer, R. (2009). Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer, 115(21), 5026-5037. [More Information]
  • Murali, R., Hughes, M., FitzGerald, P., Thompson, J., Scolyer, R. (2009). Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma. Annals of Surgery, 249(4), 641-647. [More Information]
  • Huang, S., Darfler, M., Nicholl, M., You, J., Bemis, K., Tegeler, T., Wang, M., Wery, J., Chong, K., Scolyer, R., et al (2009). LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PloS One, 4(2), e4430-1-e4430-12. [More Information]
  • Karim, R., Gerega, S., Yang, J., Spillane, A., Carmalt, H., Scolyer, R., Lee, C. (2009). Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. The Breast, 18(3), 165-170. [More Information]
  • Mandal, R., Murali, R., Lundquist, K., Ragsdale, B., Heenan, P., McCarthy, S., Mihm, M., Scolyer, R., Zembowicz, A. (2009). Pigmented Epithelioid Melanocytoma: Favorable Outcome After 5-year Follow-up. American Journal of Surgical Pathology, 33(12), 1778-1782. [More Information]
  • Shingde, M., Buckland,, M., Busam, K., McCarthy, S., Wilmott, J., Thompson, J., Scolyer, R. (2009). Primary cutaneous Ewing sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis. Journal of Clinical Pathology, 62(10), 915-919. [More Information]
  • Spillane, A., Cheung, B., Stretch, J., Scolyer, R., Shannon, K., Quinn, M., Saw, R., McCarthy, W., Thompson, J. (2009). Proposed quality standards for regional lymph node dissections in patients with melanoma. Annals of Surgery, 249(3), 473-480. [More Information]
  • Karim, R., Gerega, S., Yang, J., Horvath, L., Spillane, A., Carmalt, H., Scolyer, R., Lee, C. (2009). Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours. Journal of Clinical Pathology, 62(11), 1016-1020. [More Information]
  • Gzell, C., Carroll, S., Suchowerska, N., Beith, J., Tan, K., Scolyer, R. (2009). Radiation recall dermatitis after pre-sensitization with pegylated liposomal doxorubicin. Cancer Investigation, 27(4), 397-401. [More Information]
  • Karim, R., Li, W., Sanki, A., Colman, M., Yang, J., Thompson, J., Scolyer, R. (2009). Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. International Journal of Surgical Pathology, 17(5), 361-367. [More Information]
  • Howman-Giles, R., Shaw, H., Scolyer, R., Murali, R., Wilmott, J., McCarthy, S., Uren, R., Thompson, J. (2009). Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients. Annals of Surgical Oncology, 17(1), 138-143. [More Information]
  • Mocellin, S., Thompson, J., Pasquali, S., Montesco, M., Pilati, P., Nitti, D., Saw, R., Scolyer, R., Stretch, J., Rossi, C. (2009). Sentinel Node Status Prediction by Four Statistical Models Results From a Large Bi-Institutional Series (n=1132). Annals of Surgery, 250(6), 964-969. [More Information]
  • Martin, R., Murali, R., Scolyer, R., FitzGerald, P., Colman, M., Thompson, J. (2009). So-called "malignant blue nevus": a clinicopathologic study of 23 patients. Cancer, 115(13), 2949-2955. [More Information]
  • Sanki, A., Scolyer, R., Thompson, J. (2009). Surgery for melanoma metastases of the gastrointestinal tract: Indications and results. European Journal of Surgical Oncology, 35, 313-319. [More Information]
  • Sanki, A., Uren, R., Moncrieff, M., Tran, K., Scolyer, R., Lin, H., Thompson, J. (2009). Targeted High-Resolution Ultrasound Is Not an Effective Substitute for Sentinel Lymph Node Biopsy in Patients With Primary Cutaneous Melanoma. Journal of Clinical Oncology, 27(22), 5614-5619. [More Information]
  • Becker, T., Haferkamp, S., Dijkstra, M., Scurr, L., Frausto, M., Diefenbach, E., Scolyer, R., Reisman, D., Mann, G., Kefford, R., Rizos, H. (2009). The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Molecular Cancer, 8(4), 4-1-4-12. [More Information]
  • Ashford, R., Scolyer, R., McCarthy, S., Bonar, S., Karim, R., Stalley, P. (2009). The role of intra-operative pathological evaluation in the management of musculo-skeletal tumours. In Tunn, Per-Ulf (Eds.), Treatment of Bone and Soft Tissue Sarcomas, (pp. 11-24). Germany: Springer.

2008

  • Amersi, F., Terando, A., Goto, Y., Scolyer, R., Thompson, J., Tran, A., Faries, M., Morton, D., Hoon, D. (2008). Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clinical Cancer Research, 14(3), 638-645. [More Information]
  • Van Es, S., Colman, M., Thompson, J., McCarthy, S., Scolyer, R. (2008). Angiotropism is an Independent Predictor of Local Recurrence and In-transit Metastasis in Primary Cutaneous Melanoma. American Journal of Surgical Pathology, 32(9), 1396-403. [More Information]
  • Beavis, A., Dawson, M., Doble, P., Scolyer, R., Bourne, R., Li, L., Murali, R., Stretch, J., Lean, C., Uren, R., Thompson, J. (2008). Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma-Mass Spectrometry. Annals of Surgical Oncology, 15(3), 934-940. [More Information]
  • Moncrieff, M., Scolyer, R., Thompson, J., Beavis, A., Uren, R., Stretch, J. (2008). Correct identification of a sentinel node postselective lymphadenectomy using antimony levels. Melanoma Research, 18(5), 365-366. [More Information]
  • Murali, R., Loughman, N., McKenzie, P., Watson, G., Thompson, J., Scolyer, R. (2008). Cytologic Features of Metastatic and Recurrent Melanoma in Patients With Primary Cutaneous Desmoplastic Melanoma. American Journal of Clinical Pathology, 130(5), 715-723. [More Information]
  • Chen, J., Hruby, G., Scolyer, R., Murali, R., Hong, A., FitzGerald, P., Pham, T., Quinn, M., Thompson, J. (2008). Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer, 113(10), 2770-2778. [More Information]
  • Doubrovsky, A., Scolyer, R., Murali, R., McKenzie, P., Watson, G., Lee, C., McLeod, D., McCarthy, W., Uren, R., Stretch, J., Saw, R., Thompson, J. (2008). Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management. Annals of Surgical Oncology, 15(1), 323-332. [More Information]
  • Shipman, A., Agero, A., Cook, I., Scolyer, R., Craig, P., Pas, H., Wojnarowska, F., Murrell, D. (2008). Epidermolysis bullosa acquisita requiring multiple oesophageal dilatations. Clinical and Experimental Dermatology, 33(6), 787-9. [More Information]
  • Karim, R., Scolyer, R., Li, W., Yee, V., McKinnon, J., Li, L., Uren, R., Lam, S., Beavis, A., Dawson, M., Thompson, J., et al (2008). False Negative Sentinel Lymph Node Biopsies in Melanoma May Result From Deficiencies in Nuclear Medicine, Surgery, or Pathology. Annals of Surgery, 247(6), 1003-1010. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2008). Fine-needle biopsy as a diagnostic technique for metastatic melanoma. Expert Opinion on Medical Diagnostics, 2, 1-10.
  • Moncrieff, M., Kroon, H., Kam, P., Stalley, P., Scolyer, R., Thompson, J. (2008). Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity. Annals of Surgical Oncology, 15(10), 2749-2756. [More Information]
  • Warner, R., Quinn, M., Hruby, G., Scolyer, R., Uren, R., Thompson, J. (2008). Management of Merkel Cell Carcinoma: The Roles of Lymphoscintigraphy, Sentinel Lymph Node Biopsy and Adjuvant Radiotherapy. Annals of Surgical Oncology, 15(9), 2509-2518. [More Information]
  • Scolyer, R., Murali, R., McCarthy, S., Thompson, J. (2008). Pathologic examination of sentinel lymph nodes from melanoma patients. Seminars in Diagnostic Pathology, 25(2), 100-111. [More Information]
  • Shaw, H., Scolyer, R., Thompson, J. (2008). Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology, 53(3), 345. [More Information]
  • Murali, R., Thompson, J., Scolyer, R. (2008). Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. Future Oncology, 4(4), 535-551. [More Information]
  • Karim, R., van den Berg, K., Colman, M., McCarthy, S., Thompson, J., Scolyer, R. (2008). The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology, 52(2), 130-138. [More Information]
  • Scolyer, R., Murali, R., Satzger, I., Thompson, J. (2008). The detection and significance of melanoma micrometastases in sentinel nodes. Surgical oncology, 17(3), 165-174. [More Information]
  • O'Brien, P., Davies, M., Scurry, J., Smith, A., Barton, C., Henderson, M., Saunders, D., Gloss, B., Patterson, K., et, A., Murali, R., Scolyer, R., Scurr, L., deFazio, A. (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6), 1085-1093. [More Information]
  • Gray, A., Scolyer, R. (2008). The economic analyses of the UK prospective diabetes study. Diabetic Medicine, 25(Suppl. 2), 47-57. [More Information]
  • Thompson, J., Shaw, H., Scolyer, R. (2008). The Prognostic Significance of Isolated Immunohistochemically Positive Cells in Sentinel Lymph Nodes of Melanoma Patients. The American Journal of Surgical Pathology, 32(7), 1106-7; author reply 1107-8. [More Information]
  • Tan, K., Scolyer, R., McCarthy, S., Schatz, J., Nabarro, M., Lee, K., Rusli, J., Banu, B., Fiona Bonar, S. (2008). Tumoural calcium pyrophosphate dihydrate crystal deposition disease (tophaceous pseudogout) of the hand: a report of two cases including one with a previously unreported associated florid reactive myofibroblastic proliferation. Pathology, 40(7), 719-22. [More Information]

2007

  • Thompson, J., Scolyer, R., Kefford, R., Uren, R. (2007). (Letter to the Editor) Melanoma Management in 2007. Australian Family Physician, 36(7), 487-488. [More Information]
  • Scolyer, R., Tan, K. (2007). Case 2: Unsuspected Merkel cell carcinoma. In A Zembowicz (Eds.), Critical Diagnoses in Dermatopathology, (pp. 9-19). Australia: Knowledge Books and Software.
  • McCarthy, S., Scolyer, R., Murali, R. (2007). Combined melanocytic lesion with a predominant component 105 of atypical deep penetrating nevus associated with nodal metastases. In A Zembowicz (Eds.), Cases in Dermatopathology: Common Problems in Diagnosis of Pigmented Lesions, (pp. 105-123). Australia: Knowledge Books and Software.
  • Tan, K., Thompson, J., Arnold, C., McCarthy, S., Scolyer, R. (2007). Current perspectives on the pathologic diagnosis and reporting of melanocytic tumors. Giornale Italiano di Dermatologia e Venereologia, 142, 83-97.
  • Murali, R., Doubrovsky, A., Watson, G., McKenzie, P., Lee, C., McLeod, D., Uren, R., Stretch, J., Saw, R., Thompson, J., Scolyer, R. (2007). Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. American Journal of Clinical Pathology, 127(3), 385. [More Information]
  • Tse, G., Chaiwun, B., Lau, K., Scolyer, R., Lee, C., Karim, R., Putti, T., Law, B., Lui, P., Tan, P. (2007). Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours. Journal of Clinical Pathology, 60(9), 1051-1056. [More Information]
  • Elliott, B., Scolyer, R., Suciu, S., Lebecque, S., Rimoldi, D., Gugerli, O., Musat, E., Sharma, R., Lienard, D., Keilholz, U., Thompson, J., et al (2007). Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. Clinical Cancer Research, 13(13), 3825-3830. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Hersey, P., Thompson, J., Zhang, X. (2007). Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Modern Pathology, 20(4), 416-426. [More Information]
  • Jabbour, J., Cumming, R., Scolyer, R., Hruby, G., Thompson, J., Lee, S. (2007). Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease-Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004. Annals of Surgical Oncology, 14(6), 1943-1952. [More Information]
  • Li, W., Tran, N., Lee, C., O'Brien, C., Tse, G., Scolyer, R., Hong, A., Milross, C., Yu, K., Rose, B. (2007). New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis. Pathology, 39(2), 217-222. [More Information]
  • Murali, R., Scolyer, R. (2007). Pigmented dermatofibrosarcoma protuberans (Bednar tumor). In A Zembowicz (Eds.), Cases in Dermatopathology: Common Problems in Diagnosis of Pigmented Lesions, (pp. 199-201). Australia: Knowledge Books and Software.
  • Scolyer, R., Thompson, J. (2007). Primary melanoma of the lung. The American surgeon, 73(9), 937-938. [More Information]
  • Shaw, H., Scolyer, R., Thompson, J. (2007). Re: NM patients and SN. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 5(5), 320. [More Information]
  • Sanki, A., Li, W., Colman, M., Karim, R., Thompson, J., Scolyer, R. (2007). Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma. Pathology, 39(6), 551-557. [More Information]
  • Murali, R., Sharma, R., Thompson, J., Stretch, J., Lee, C., McCarthy, S., Scolyer, R. (2007). Sentinel Lymph Node Biopsy in Histologically Ambiguous Melanocytic Tumors With Spitzoid Features (So-Called Atypical Spitzoid Tumors). Annals of Surgical Oncology, 15(1), 302-309. [More Information]
  • Tan, K., Moncrieff, M., Thompson, J., McCarthy, S., Shaw, H., Quinn, M., Li, L., Crotty, K., Stretch, J., Scolyer, R. (2007). Subungual Melanoma: A Study of 124 Cases Highlighting Features of Early Lesions, Potential Pitfalls in Diagnosis, and Guidelines for Histologic Reporting. American Journal of Surgical Pathology, 31(12), 1902-1912. [More Information]
  • Sassen, S., Shaw, H., Colman, M., Scolyer, R., Thompson, J. (2007). The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center. Annals of Surgical Oncology, 15(2), 630-637. [More Information]
  • Scolyer, R., Thompson, J., Shaw, H., McCarthy, S. (2007). The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma. Journal Of Cutaneous Pathology, 33(5), 395-396. [More Information]

2006

  • Heinzelmann-Schwarz, V., Gardiner-Garden, M., Henshall, S., Scurry, J., Scolyer, R., Smith, A., Bali, A., Vanden Bergh, P., Baron-Hay, S., Scott, C., et al (2006). A distinct molecular profile associated with mucinous epithelial ovarian cancer. British Journal of Cancer, 94(6), 904-913. [More Information]
  • Bonar, S., Viglione, W., Schatz, J., Scolyer, R., McCarthy, S. (2006). An unusual variant of intraneural ganglion of the common peroneal nerve. Skeletal Radiology, 35(3), 165-71. [More Information]
  • Murali, R., McCarthy, S., Scolyer, R. (2006). Case 16: Atypical deep penetrating nevus forming a component of a combined nevus. In A Zembowicz (Eds.), Cases in Dermatopathology: Common Problems in Diagnosis of Pigmented Lesions, (pp. 105-124). Australia: Knowledge Books and Software.
  • McCarthy, S., Crotty, K., Scolyer, R. (2006). Desmoplastic melanoma and desmoplastic neurotropic melanoma. In LeBoit P; Burg G; Weedon D; Sarasin A (Eds.), Pathology and Genetics of Skin Tumours, (pp. 76-78). Lyon: IARC Press.
  • Maclean, F., Schatz, J., McCarthy, S., Scolyer, R., Stalley, P., Bonar, S. (2006). Epithelioid and spindle cell haemangioma of bone. Skeletal Radiology, 36, S50-7. [More Information]
  • Heinzelmann-Schwarz, V., Scolyer, R., Scurry, J., Smith, A., Gardiner-Garden, M., Biankin, A., Baron-Hay, S., Scott, C., Ward, R., Fink, D., et al (2006). Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries. Journal of Clinical Pathology, 60(6), 622-626. [More Information]
  • de Vries, E., Bray, F., Coebergh, J., Cerroni, L., RUITER, D., Elder, D., Thompson, J., Barnhill, R., van Muijen, G., Scolyer, R., et al (2006). Malignant melanoma: Introduction. In LeBoit P; Burg G; Weedon D; Sarasin A (Eds.), Pathology and Genetics of Skin Tumours, (pp. 52-65). Lyon: IARC Press.
  • Dray, M., McCarthy, S., Palmer, A., Bonar, S., Stalley, P., Marjoniemi, V., Millar, E., Scolyer, R. (2006). Myopericytoma: a unifying term for a spectrum of tumours that show overlapping features with myofibroma. A review of 14 cases. Journal of Clinical Pathology, 59(1), 67-73. [More Information]
  • Karim, R., Wills, E., McCarthy, S., Scolyer, R. (2006). Myxoid variant of adrenocortical carcinoma: report of a unique case. Pathology international, 56(2), 89-94. [More Information]
  • Murali, R., Scolyer, R. (2006). Pigmented dermatofibrosarcoma protruberans (Bednar tumor). In A Zembowicz (Eds.), Cases in Dermatopathology: Common Problems in Diagnosis of Pigmented Lesions, (pp. 199-212). Australia: Knowledge Books and Software.
  • Pua, V., Scolyer, R., Barnetson, R. (2006). Pravastatin-induced lichenoid drug eruption. Australasian Journal of Dermatology, 47(1), 57-59. [More Information]
  • Thompson, J., Bishop, J., Scolyer, R. (2006). Primary melanoma of the lung. In Derek Raghavan, Martin L Brecher and David H Johnson etal (Eds.), Textbook of Uncommon Cancer, (pp. 293-297). United States: John Wiley & Sons.
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Zhang, X., Thompson, J., Screaton, G., Hersey, P. (2006). Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Human Pathology, 37(10), 1286-1294. [More Information]
  • Ashford, R., McCarthy, S., Scolyer, R., Bonar, S., Karim, R., Stalley, P. (2006). Surgical biopsy with intra-operative frozen section: AN ACCURATE AND COST-EFFECTIVE METHOD FOR DIAGNOSIS OF MUSCULOSKELETAL SARCOMAS. Journal of Bone and Joint Surgery: British Volume, 88(9), 1207-1211. [More Information]
  • Thompson, J., Scolyer, R., Uren, R. (2006). Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surgical Oncology Clinics of North America, 15(2), 301-18. [More Information]
  • Shaw, H., Quinn, M., Scolyer, R., Thompson, J. (2006). Survival in patients with desmoplastic melanoma. Journal of Clinical Oncology, 24(8), e12-e12. [More Information]
  • Li, W., Sanki, A., Karim, R., Thompson, J., Soon, L., Zhuang, L., McCarthy, S., Scolyer, R. (2006). The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology, 38(4), 287-301. [More Information]

2005

  • van Poll, D., Thompson, J., Colman, M., McKinnon, J., Saw, R., Stretch, J., Scolyer, R., Uren, R. (2005). A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(8), 597-608. [More Information]
  • Zhuang, L., Lee, C., Scolyer, R., McCarthy, S., Palmer, A., Zhang, X., Thompson, J., Bron, L., Hersey, P. (2005). Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. Journal of Clinical Pathology, 58(11), 1163-1169. [More Information]
  • Armour, K., Scolyer, R., Barnetson, R. (2005). Borderline lepromatous leprosy presenting as a single cutaneous plaque. Australasian Journal of Dermatology, 46(3), 181-183. [More Information]
  • Scolyer, R. (2005). Case 12: Nipple Adenoma. In A Zembowicz (Eds.), Cases in Dermatopathology: Adnexal Neoplasms, (pp. 83-98). Australia: Knowledge Books and Software.
  • Scolyer, R. (2005). Case 13: Digital Papillary Adenocarcinoma. In A Zembowicz (Eds.), Cases in Dermatopathology: Adnexal Neoplasms, (pp. 99-109). Australia: Knowledge Books and Software.
  • Karim, R., Rose, B., Brammah, S., Scolyer, R. (2005). Condylomata acuminata of the urinary bladder with HPV 11. Pathology, 37(2), 176-178. [More Information]
  • Thompson, J., Scolyer, R., Kefford, R. (2005). Cutaneous melanoma. The Lancet, 365(9460), 687-701. [More Information]
  • Scolyer, R., Thompson, J. (2005). Desmoplastic melanoma: a heterogeneous entity in which subclassification as pure" or "mixed" may have important prognostic significance.". Annals of Surgical Oncology, 12(3), 197-9. [More Information]
  • Kim, Y., Scolyer, R., Chia, E., Steven, D., Ghabrial, R. (2005). Eccrine porocarcinoma of the upper eyelid. The Australasian Journal of Dermatology, 46(4), 278-81. [More Information]
  • Bron, L., Scolyer, R., Thompson, J., Hersey, P. (2005). Histological expression of tumour necrosis factor-related apotosis-induced ligand (TRAIL) in human primary melanoma. Pathology, 36(6), 561-565. [More Information]
  • McKinnon, J., Starritt, E., Scolyer, R., McCarthy, W., Thompson, J. (2005). Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick. Annals of Surgery, 241(2), 326-333. [More Information]
  • Bourne, R., Stanwell, P., Stretch, J., Scolyer, R., Thompson, J., Mountford, C., Lean, C. (2005). In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. European Journal of Radiology, 53(3), 506-513. [More Information]
  • Scolyer, R., Thompson, J., McCarthy, S., Gershenwald, J., Ross, M., Cochran, A. (2005). Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. Journal of the American College of Surgeons, 201(5), 821-3; author reply 823-4. [More Information]
  • de Wilt, J., Farmer, S., Scolyer, R., McCaughan, B., Thompson, J. (2005). Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour? Melanoma Research, 15(6), 531-537. [More Information]
  • Stretch, J., Thompson, J., Scolyer, R., Mountford, C., Lean, C. (2005). Magnetic resonance spectroscopy in the management of melanoma. Cancer Forum, 29(2), 73-76.
  • Stretch, J., Somorjai, R., Bourne, R., Hsiao, E., Scolyer, R., Dolenko, B., Thompson, J., Mountford, C., Lean, C. (2005). Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples. Annals of Surgical Oncology, 12(11), 943-949. [More Information]
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2005). Micromorphometric features of positive sentinel nodes predict involvement of non-sentinel nodes in patients. United States: Mosby.
  • Yee, V., Thompson, J., McKinnon, J., Scolyer, R., Li, L., McCarthy, W., O'Brien, C., Quinn, M., Saw, R., Shannon, K., Stretch, J., Uren, R. (2005). Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Annals of Surgical Oncology, 12(6), 429-439. [More Information]
  • Thompson, J., Uren, R., Stretch, J., Scolyer, R. (2005). Selective sentinel lymphadenectomy: progress to date and prospects for the future. Cancer Treatment and Research, 127(Supplement), 269-287. [More Information]
  • Tse, G., Tsang, A., Putti, T., Scolyer, R., Lui, P., Law, B., Karim, R., Lee, C. (2005). Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours. Journal of Clinical Pathology, 58(2), 185-189. [More Information]
  • Tse, G., Wong, F., Tsang, A., Lee, C., Lui, P., Lo, A., Law, B., Scolyer, R., Karim, R., Putti, T. (2005). Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. Journal of Clinical Pathology, 58(6), 600-604. [More Information]
  • Weber, F., Byrne, S., Le, S., Brown, D., Breit, S., Scolyer, R., Halliday, G. (2005). Transforming growth factor-b1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system. Cancer Immunology, Immunotherapy: other biological response modifications, 54(9), 898-906. [More Information]
  • Starritt, E., Uren, R., Scolyer, R., Quinn, M., Thompson, J. (2005). Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Annals of Surgical Oncology, 12(1), 18-23. [More Information]

2004

  • Harper, C., Scolyer, R. (2004). Alcoholism and dementia. In Margaret M. Esiri, Virginia Lee, John Q. Trojanowski (Eds.), The Neuropathology of Dementia. 2nd edition, (pp. 427-441). Cambridge University Press.
  • Scolyer, R., Thompson, J., Li, L., Beavis, A., Dawson, M., Doble, P., Soper, R., Uren, R., Stretch, J., Sharma, R., et al (2004). Antimony Concentrations In Nodal Tissue Can Confirm Sentinel Node Identity. Modern Pathology, 17(10), 1191-1197.
  • Scolyer, R., Zhuang, L., Palmer, A., Thompson, J., McCarthy, S. (2004). Combined Naevus: A Benign Lesion Frequently Misdiagnosed Both Clinically And Pathologically As Melanoma. Pathology, 36(5), 419-427.
  • Thompson, J., Scolyer, R. (2004). Cooperation Between Surgical Oncologists And Pathologists: A Key Element Of Multidisciplinary Care For Patients With Cancer. Pathology, 36(5), 496-503.
  • de Wilt, J., Thompson, J., Uren, R., Ka, V., Scolyer, R., McCarthy, W., O'Brien, C., Quinn, M., Shannon, K. (2004). Correlation Between Preoperative Lymphoscintigraphy And Metastatic Nodal Disease Sites In 362 Patients With Cutaneous Melanomas Of The Head And Neck. Annals of Surgery, 239(4), 544-552.
  • Sarris, M., Scolyer, R., Konopka, M., Thompson, J., Harper, C., Lee, S. (2004). Cytoplasmic Expression Of Nm23 Predicts The Potential For Cerebral Metastasis In Patients With Primary Cutaneous Melanoma. Melanoma Research, 14(1), 23-27.
  • McCarthy, S., Scolyer, R., Palmer, A. (2004). Desmoplastic Melanoma: A Diagnostic Trap For The Unwary. Pathology, 36(5), 445-451.
  • Scolyer, R., Thompson, J., Li, L., Beavis, A., Dawson, M., Doble, P., Ka, V., McKinnon, J., Soper, R., Uren, R., Shaw, H., Stretch, J., McCarthy, S. (2004). Failure To Remove True Sentinel Nodes Can Cause Failure Of The Sentinel Node Biopsy Technique: Evidence From Antimony Concentrations In False-Negative Sentinel Nodes From Melanoma Patients. Annals of Surgical Oncology, 11(Supplement 3), 174S-178S.
  • Bron, L., Scolyer, R., Thompson, J., Hersey, P. (2004). Histological Expression Of Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) In Human Primary Melanoma. Pathology, 36(6), 561-565.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2004). Immunohistochemical Stains Fail To Increase The Detection Rate Of Micrometastatic Melanoma In Completion Regional Lymph Node Dissection Specimens. Melanoma Research, 14(4), 263-268.
  • Tse, G., Putti, T., Lui, P., Lo, A., Scolyer, R., Law, B., Karim, R., Lee, C. (2004). Increased C-Kit (Cd117) Expression In Malignant Mammary Phyllodes Tumors. Modern Pathology, 17(7), 827-831.
  • Scolyer, R., Li, L., McCarthy, S., Shaw, H., Stretch, J., Sharma, R., Thompson, J. (2004). Micromorphometric Features Of Positive Sentinel Lymph Nodes Predict Involvement Of Nonsentinel Nodes In Patients With Melanoma. American Journal of Clinical Pathology, 122(4), 532-539.
  • Karim, R., Ma-Wyatt, J., Cox, M., Scolyer, R. (2004). Myoid Angioendothelioma Of The Spleen. International Journal of Surgical Pathology, 12(1), 51-56.
  • Heinzelmann-Schwarz, V., Gardiner-Garden, M., Henshall, S., Scurry, J., Scolyer, R., Davies, M., Heinzelmann, M., Kalish, L., Bali, A., Kench, J., et al (2004). Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clinical Cancer Research, 10(13), 4427-4436. [More Information]
  • Scolyer, R., Bonar, S., Palmer, A., Barr, E., Wills, E., Stalley, P., Schatz, J., Soper, J., Li, L., McCarthy, S. (2004). Parachordoma Is Not Distinguishable From Axial Chordoma Using Immunohistochemistry. Pathology international, 54(5), 364-370.
  • Scolyer, R., Thompson, J., Stretch, J., Sharma, R., McCarthy, S. (2004). Pathology Of Melanocytic Lesions: New, Controversial, And Clinically Important Issues. Journal of Surgical Oncology, 86(4), 200-211. [More Information]
  • Zborowska, B., Ell, J., McGee-Collett, M., Scolyer, R., McCluskey, P. (2004). Progressive visual loss in a patient with presumed temporal arteritis despite treatment: how to make the diagnosis. Clinical and Experimental Ophthalmology, 32, 335-336.
  • Thompson, J., Stretch, J., Uren, R., Ka, V., Scolyer, R. (2004). Sentinel Node Biopsy For Melanoma: Where Have We Been And Where Are We Going? Annals of Surgical Oncology, 11(Supplement 3), 147S-151S.
  • Doubrovsky, A., De Wilt, J., Scolyer, R., McCarthy, W., Thompson, J. (2004). Sentinel Node Biopsy Provides More Accurate Staging Than Elective Lymph Node Dissection In Patients With Cutaneous Melanoma. Annals of Surgical Oncology, 11(9), 829-836.
  • Tse, G., Lui, P., Lee, C., Kung, F., Scolyer, R., Law, B., Lau, T., Karim, R., Putti, T. (2004). Stromal Expression Of Vascular Endothelial Growth Factor Correlates With Tumor Grade And Microvessel Density In Mammary Phyllodes Tumors: A Multicenter Study Of 185 Cases. Human Pathology, 35(9), 1053-1057. [More Information]
  • Li, W., Thompson, C., Cossart, Y., O'Brien, C., McNeil, E., Scolyer, R., Rose, B. (2004). The Expression Of Key Cell Cycle Markers And Presence Of Human Papillomavirus In Squamous Cell Carcinoma Of The Tonsil. Head and Neck, 26(1), 1-9. [More Information]
  • Haviv, M., Scolyer, R. (2004). The First Laurent Series Coefficients For Singularly Perturbed Stochastic Matrices'. Linear Algebra and its Applications, 386, 243-259.
  • Thompson, J., Shaw, H., Hersey, P., Scolyer, R. (2004). The History And Future Of Melanoma Staging. Journal of Surgical Oncology, 86(4), 224-235. [More Information]
  • Francken, A., Shaw, H., Thompson, J., Soong, S., Accortt, N., Azzola, M., Scolyer, R., Milton, G., McCarthy, W., Colman, M., et al (2004). The Prognostic Importance Of Tumor Mitotic Rate Confirmed In 1317 Patients With Primary Cutaneous Melanoma And Long Follow-Up. Annals of Surgical Oncology, 11(4), 426-433.
  • Karim, R., Tse, G., Putti, T., Scolyer, R., Lee, C. (2004). The Significance Of The Wnt Pathway In The Pathology Of Human Cancers. Pathology, 36(2), 120-128.
  • Li, W., Thompson, C., Cossart, Y., O'Brien, C., Liu, J., Scolyer, R., Carter, J., Dalrymple, C., Rose, B. (2004). The Site Of Infection And Ethnicity Of The Patient Influence The Biological Pathways To Hpv-Induced Mucosal Cancer. Modern Pathology, 17(9), 1031-1037.
  • Wells, J., Kosky, C., Scolyer, R., Lee, S., Bye, P., Young, G., Davies, L. (2004). Unusual Case Of Subcutaneous Panniculitis-Like T-Cell Lymphoma. Australasian Journal of Dermatology, 45(2), 114-118. [More Information]
  • Abe, K., Abe, K., Abe, T., Adachi, I., Scolyer, R., Aihara, H., Akai, K., Akatsu, M., Akemoto, M., Asano, Y., Bakich, A., Parslow, N., et al (2004). Upper Bound On The Decay Tau ->Mu Gamma From The Belle Detector. Physical Review Letters, 92(17), 171802-1-171802-6.
  • Stewart, M., Scolyer, R. (2004). User Needs Analysis And Development Of Priorities For Life Cycle Impact Assessment. International Journal of Life Cycle Assessment, 9(3), 153-160.

2003

  • Li, W., Thompson, C., Xin, D., Cossart, Y., O'Brien, C., McNeil, E., Gao, K., Scolyer, R., Rose, B. (2003). Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. The American Journal of Pathology: cellular and molecular biology of disease, 163(6), 2185-2189.
  • Dawson, M., Doble, P., Beavis, A., Li, L., Soper, R., Scolyer, R., Uren, R., Thompson, J. (2003). Antimony by ICP-MS as a marker for sentinel lymphnodes in melanoma patients. The Analyst, 128(3), 217-219.
  • Li, L., Crotty, K., Palmer, A., Kril, J., Scolyer, R., Thompson, J., Li, L., McCarthy, S. (2003). Argyrophilic staining of nucleolar organizer region count and morphometry in benign and melignant melanocytic lesions. American Journal Of Dermatopathology, 25(3), 190-197.
  • Li, W., Thompson, C., O'Brien, C., McNeil, E., Scolyer, R., Cossart, Y., Veness, M., Walker, D., Morgan, G., Rose, B. (2003). Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. International Journal of Cancer, 106(4), 553-558. [More Information]
  • Slater, M., Scolyer, R., Gidley-Baird, A., Thompson, J., Barden, J. (2003). Increased expression of apoptotic markers in melanoma. Melanoma Research, 13(2), 137-145.
  • Scolyer, R., Shaw, H., Thompson, J., Li, L., Colman, M., Lo, S., McCarthy, S., Palmer, A., Nicoll, K., Dutta, B., Stretch, J., et al (2003). Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. American Journal of Surgical Pathology, 27(12), 1571-1576.
  • Li, L., Scolyer, R., Ka, V., McKinnon, J., Shaw, H., McCarthy, S., Thompson, J. (2003). Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional Recurrence: A Clinicopathologic Study of 1152 Patients Undergoing Sentinel Lymph Node Biopsy. American Journal of Surgical Pathology, 27(9), 1197-1202.
  • Lean, C., Bourne, R., Thompson, J., Scolyer, R., Stretch, J., Li, L., Russell, P., Mountford, C. (2003). Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biospy specimens. Melanoma Research, 13(3), 259-261.
  • Azzola, M., Shaw, H., Thompson, J., Soong, S., Scolyer, R., Watson, G., Colman, M., Zhang, Y. (2003). Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: An analysis of 3661 patients from a single center. Cancer, 97(6), 1488-1498. [More Information]
  • Li, L., Crotty, K., Scolyer, R., Thompson, J., Kril, J., Palmer, A., McCarthy, S. (2003). Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyophilic staining of nucleolar organizer regions and MIBI1-Ki67 immunoreactivity. Melanoma Research, 13(6), 581-586.

2002

  • Li, L., Crotty, K., Palmer, A., Kril, J., Stankovic, R., Scolyer, R., McCarthy, S. (2002). Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation. Analytical and Quantitative Cytology and Histology, 24(4), 234-243.
  • Tse, G., Soon, L., Kung, F., Scolyer, R., Law, B., Lau, T., Putti, T. (2002). Hormonal Receptors Expression in Epithelial Cells of Mammary Phyllodes Tumors Correlates with Pathologic Grade of the Tumor A Multicenter Study of 143 Cases. American Journal of Clinical Pathology, 118(4), 522-526.
  • Li, L., Crotty, K., Palmer, A., Kril, J., Scolyer, R., McCarthy, S. (2002). Melanin bleaching in argyrophilic staining of agNORs in pigmented lesions. Analytical and Quantitative Cytology and Histology, 24(3), 166-172.

2001

  • Lee, C., Scolyer, R., McKenzie,, P., Achmed, D. (2001). Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology? Pathology, 33, 437-443.
  • Scolyer, R., McKenzie, P., Achmed, D., Lee, C. (2001). Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology? Pathology, 1, 2389-2392.
  • Harper, C., Buckland,, M., Scolyer, R., Donellan, M., Brew, S., McGee-Collett, M. (2001). Spinal chloroma presenting with triplegia in an aleukaemic patient. Pathology, 33, 386-389.

To update your profile click here. For support on your academic profile contact .